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Abstract 
Staphylococcus aureus, a human commensal and pathogen, is capable of forming biofilms on a 
variety of host tissues and implanted medical devices.  Biofilm-associated infections resist 
antimicrobial chemotherapy and attack from the host immune system, making these infections 
particularly difficult to treat.  To gain insight into environmental conditions that influence S. 
aureus biofilm development, we screened a library of small molecules for the ability to inhibit S. 
aureus biofilm formation.  This led to the finding that the polyphenolic compound tannic acid 
inhibits S. aureus biofilm formation in multiple biofilm models without inhibiting bacterial 
growth.  We present evidence that tannic acid inhibits S. aureus biofilm formation via a 
mechanism dependent upon the putative transglycosylase IsaA.  Tannin-containing drinks like 
tea have been found to reduce methicillin-resistant S. aureus nasal colonization; we found that 
black tea inhibited S. aureus biofilm development and that an isaA mutant resisted this 
inhibition.   We developed a rodent model for S. aureus throat colonization and found that tea 
consumption reduced S. aureus throat colonization via an isaA-dependent mechanism.   
We also showed two distinct mechanisms by which S. aureus adapts to resist tannic acid stress.  
First, when the dedicated regulator of the Sigma B stress response system, rsbU, is mutated, the 
cells overproduce extracellular proteases, clearing IsaA from the extracellular milieu.  Second, 
when the serine threonine kinase pknB is mutated, PIA (a major component of the biofilm 
matrix) is overproduced, which we hypothesize strengthens the overall structure of the matrix, 
conferring resistance to tannic acid.  These findings provide insight into a molecular mechanism 
by which commonly consumed polyphenolic compounds, such as tannins, influence S. aureus 
surface colonization, as well as how bacteria can adapt to evade such antibiofilm treatments.  
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CHAPTER 1 
General introduction 
Staphylococcus aureus 
In 1880, a Scottish surgeon named Alexander Ogston began investigating the cause of abscess 
wounds found on his patients.  He hypothesized that the abscesses were the result of infecting 
microorganisms.  Observing stained pus under a microscope, Ogston saw two different types of 
microbes 1,2.  One, growing in chains, was the already-described Streptococcus.  The other was a 
novel bacterium that he described as appearing in clusters “like the roe of fish.”  He later named 
this second type Staphylococcus 3. 
Among the Staphylococci, Staphylococcus aureus is of particular interest today.  S. aureus is 
best known as a versatile pathogen, causing bacteremia, endocarditis, sepsis, skin and soft tissue 
infections, implanted device infections, and several other relevant human diseases 3–9. The 
mortality of patients with S. aureus bacteremia in the pre-antibiotic era exceeded 80%, and over 
70% developed metastatic infections 10.  Considering that S. aureus kills approximately 19,000 
Americans annually (significantly more than AIDS) and the fact that S. aureus antibiotic 
resistance is rapidly increasing 11, there is an urgent need to better understand this pathogen and 
develop novel treatment strategies.   
S. aureus is also able to colonize a host non-pathogenically.  This sort of commensal 
colonization is very common in the human nose, throat, and on several other body sites 12–14.  
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The proportion of people who are colonized varies depending on the specific population under 
study, but it is commonly agreed upon that approximately 20-50% of the healthy adult 
population is colonized with S. aureus in their noses 12,15,16.  Colonization is a major risk factor 
for Staphylococcal disease 17; for example, several studies have found surgical patients have a 7-
10 fold increase in the likelihood of developing S. aureus surgical site infections if they are 
nasally colonized 18,19. 
Biofilms 
For a century and a half, scientists primarily studied bacteria shaking in rich liquid media.  
Although this allowed us to understand many facets of bacterial form, physiology, and 
metabolism, the picture we saw was incomplete because these conditions do not represent the 
spectrum of lifestyles that bacteria live.  Whether we are discussing environmental bacteria 
growing on river rocks or pathogens growing on a damaged heart valve, many bacteria live much 
of their lives attached to surfaces.  Figure 1 shows an electron micrograph of a surface-attached 
community (termed a biolfilm) of S. aureus growing on a catheter.  The study of bacteria in 
biofilms, largely pioneered by Costerton, opened up completely novel ideas about how bacteria 
live and interact with their environment 20. 
The biofilm matrix 
Biofilms are found encased in a polymeric matrix.  Although producing this matrix is costly, it 
allows the bacterial community to survive a wide array of insults and harsh environments.  The 
exact composition of this matrix varies tremendously depending on both the environmental 
conditions and the specific bacteria that compose the biofilm.  Despite this variability, there are a 
few classes of molecules that are typically represented in the matrix, and are generally agreed 
upon to be the major components.  These classes are protein adhesins, extracellular DNA 
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(eDNA), polysaccharide, and amyloid fibers.  A brief overview of these macromolecules and a 
few representatives from each class follows. 
Protein adhesins 
There are many different proteins involved in surface adhesion, and their roles are often highly 
redundant and poorly understood.  Microbial Surface Components Recognizing Adhesive Matrix 
Molecules (MSCRAMMs) specifically recognize and interact with host factors to facilitate 
attachment of bacteria to surfaces within a host 21.  These include proteins that bind to 
fibronectin, fibrinogen, collagen, and other host proteins. 
An example of a protein adhesin, biofilm-associated protein (Bap) was discovered in certain S. 
aureus strains as a cell wall-anchored protein mediating initial attachment to biotic and abiotic 
surfaces 22.  Further investigation revealed Bap homologs in Enterococcus faecalis 23, E. coli 24, 
Salmonella enteritidis 25, and other species.  
eDNA 
eDNA is a major structural component of biofilms formed by many species.  The importance of 
this component in biofilms formed by many species can be seen in the fact that exogenous 
DNase addition can either inhibit or disperse biofilms of E. coli 26, P. aeruginosa 27, N. 
gonorrhoeae 28, S. aureus 29, and others. 
Matrix eDNA can come from several sources.  In many cases, it comes from autolysis of a 
subpopulation of cells in the biofilm.  This autolysis can result from either an altruistic, suicidal 
mechanism 30 or through a coordinated fratricidal mechanism whereby the whole population 
produces a toxin, and all but a small subset also produce the antitoxin, thereby lysing a 
subpopulation to release eDNA 31.   
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eDNA can also be generated without lysis.  DNA has been found to be released through 
membrane vesicles by several gram negative bacteria, including P. aeruginosa, E. coli, S. 
typhimurium, and Y. pestis 32,33.  These DNA-containing vesicles have been shown to promote 
biofilm formation, though the specific role of the DNA itself remains controversial.  DNA can 
also be released from N. gonorrhoeae by a type IV secretion system 34.   
Amyloids 
Amyloids are incredibly resilient fibers that form from protein oligomers.  Although amyloids 
were originally thought to be the result of protein folding error (and therefore associated only 
with various human disease states), work by Chapman and others showed that amyloids can be 
functional 35.  The most studied functional amyloids are those that stabilize the biofilm matrix. 
Amyloids share many properties due to a unique fold, but the primary structure of the protein 
monomers is not conserved.  This means that the amyloid components of biofilms formed by 
many species of bacteria are diverse.  For example, Bacillus subtilis produces amyloids formed 
of the 261-residue TasA 36, while S. aureus makes its amyloids of the Phenol Soluble Modulin 
(PSM) peptides, which are as small as 20 residues long 37.  Some, like the PSMs, have multiple 
functions, while others, such as E. coli’s CsgA, appear to have the sole function of stabilizing the 
biofilm 35,38. 
Polysaccharides 
The polysaccharide component of the biofilm matrix is thought to be generally the most 
abundant.  Although matrix composition is highly variable, it is estimated that on average 50-
90% of the organic carbon in a biofilm is found in the polysaccharide 39.  Like the other 
components of the biofilm matrix, the polysaccharide component is diverse.  Different bacteria 
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produce dramatically different polysaccharides.  E. coli and Salmonella typhimurium, for 
example, produce the uncharged, homopolymeric cellulose 40.  S. aureus, by contrast, produces a 
polycationic homopolymer called Polysaccharide Intercelluar Adhesin (PIA) 41.  Streptococcus 
thermophilus produces three distinct heteropolymeric polysaccharides as part of its biofilm 
matrix 42.  
These polysaccharides can play many roles in the biofilm, including aiding in initial adherence to 
a surface 43, adding structural stability 44, serving as a nutrient storage reservoir 45, retaining 
water to prevent desiccation 46, and protecting from the host immune system 47. 
Biofilms in a human host 
Bacterial biofilms are found in diverse environments, including industrial (such as Pseudomonas 
aeruginosa in the pipes in water treatment plants 48), natural (such as Legionella pneumophila in 
freshwater lakes 49), and clinical (such as S. aureus on a damaged heart valve 50).  Of particular 
interest to this work are biofilms that grow in and on a human host. 
There is controversy in the field of biofilm study about whether or not bacteria are in a biofilm 
state when colonizing various host sites.  Much of this controversy is a result of definitional 
arguments about what constitutes a biofilm.  Resolving this conflict is not trivial.  One problem 
is the lack of a single defining physiological marker of the biofilm state.  Further, because 
biofilms are by definition a coordinated group lifestyle in response to physiological and 
environmental conditions, biofilms cannot easily be removed from the host and studied ex vivo 
without causing them to revert to a disorganized state.  To simplify the discussion of biofilms in 
a human host, the term “biofilm” will be used somewhat loosely to encompass circumstances 
where cells are living in microcolonies attached to, or associated with, a surface. 
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The interactions of biofilms with their human hosts fall on a spectrum from mutualistic to 
parasitic.  On the mutualistic end, we have interactions like the one occurring in the large 
intestine.  There, a diverse population of microbes forms a complex, multispecies biofilm on the 
gut epithelial surface.  The benefits to the bacteria include a safe, nutrient rich environment 
where temperature is constant and waste is removed by the host.  The bacteria, in turn, benefit 
the host by aiding in digestion and excluding pathogens 51.   
On the far end of the spectrum from this interaction, there are many examples of disease-
associated biofilms.  Dental caries are caused by acid produced by a multispecies biofilm 
growing on teeth 52.  Urinary tract infections involve E. coli and other species growing within 
epithelial cells of the urinary tract as biofilms 53.   S. aureus biofilms growing on damaged heart 
valves can cause infective endocarditis, leading to impaired heart function, bloodstream 
infections, and embolisms 54.  Lungs of cystic fibrosis (CF) patients are densely colonized with 
biofilms consisting primarily of P. aeruginosa.  Although the lungs are typically sterile, CF 
patients are persistently colonized for the rest of their lives 55.  Indwelling devices rapidly 
become coated in a biofilm of S. aureus or S. epidermidis, which can only be cleared by 
surgically removing and replacing the device 56,57. 
Between the two extremes of mutualism and parasitism, bacteria can also colonize host surfaces 
in a commensal fashion.  Streptococcus pneumoniae colonizes the human nasopharynx 
asymptomatically 58.  Clostridium difficile is a common colonizer in human intestines, 
particularly in infants 59.  The human skin is teaming with diverse bacteria, notably 
Staphylococcus epidermidis 60.  S. aureus commensally colonizes the human nose, throat, and 
other body sites 12. 
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These categories of symbiosis are not fixed, but rather fluid. S. pneumoniae living as a 
commensal in the nasopharynx can, under certain circumstances, invade the inner ear to cause 
otitis media 61, the respiratory tract to cause pneumonia 62, or the blood to cause meningitis 63.  
When antibiotics perturb the normal flora of the gut, C. difficile can transition from its 
commensal state to cause severe diarrhea.   
Of particular interest to this work is S. aureus’ transition from commensal to pathogen.  Surgical 
patients who carry S. aureus in their nose have a 7-fold increase in their risk of S. aureus surgical 
site infection.  In those who are infected, 30-100% are infected by the same strain that inhabited 
their nose prior to surgery, suggesting that the bacteria traveled from the nose to the surgical site, 
invaded, and colonized new surfaces there 18. 
Biofilm Regulation 
Biofilms form when planktonic bacteria attach to a surface, proliferate on that surface, and 
encase themselves in a polymeric matrix (Figure 2).  These phases of the biofilm lifecycle are 
tightly regulated.  However, because biofilms are so diverse, there is no single, ubiquitous 
biofilm regulatory system.  Even within a specific species, the regulation can differ among 
different types of biofilm formed under different growth conditions.  Therefore, a comprehensive 
review of all biofilm regulatory pathways is impractical for this document.  Instead, this section 
will focus on biofilm regulation in S. aureus, as it is the most relevant organism to the rest of this 
work.   
The best studied mode of biofilm regulation in S. aureus is regulation of the polysaccharide 
component of the biofilm matrix, the Polysaccharide Intercelluar Adhesin (PIA).  PIA is 
produced by the enzymes encoded in the Intercellular Adhesin (ica) operon.  The ica genes were 
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discovered in a transposon screen of S. epidermidis, looking for genes that were important for 
biofilm formation 64 and further investigation revealed homologues in S. aureus 65.  At the time 
of their discovery, the ica genes were thought to be indispensable for biofilm formation in S. 
aureus.    
The S. aureus ica locus consists of five genes: the icaADBC operon and the divergently 
transcribed regulatory gene icaR.  IcaA and IcaD work together to produce short oligomers of N-
acetylglucosamine, about 20 sugars long 66.  IcaC is thought to be responsible for transporting 
the oligomers across the membrane to the outside of the cell.  IcaB deacetylates the polymer, 
allowing it to be attached to the cell surface and to participate in biofilm formation 67.  IcaR is a 
tetR family transcriptional repressor 68. 
PIA production (and therefore PIA-dependent biofilm formation) is controlled by several genetic 
regulatory systems.  Spx regulates a number of cell functions in response to the redox state of the 
cell.  When Spx is active, icaR expression is increased, decreasing PIA production 69.  Another 
global regulator, SarA (Staphylococcal Accessory Regulator), is required for ica transcription  70.  
It is worth noting that, although SarA regulates expression of agr (another master regulator to be 
discussed later in this section), SarA’s regulation of ica is agr-independent.  σB, a master 
regulator of the S. aureus stress response, has been shown both to regulate PIA production 70 and 
not to regulate PIA production 71, indicating that σB involvement in biofilm regulation and PIA 
production is complex and likely dependent on strain and/or growth conditions.   
In addition to these genetic regulation mechanisms, several environmental conditions have been 
shown to regulate PIA production.  Subinhibitory concentrations of certain antibiotics, including 
tetracycline, increase ica expression through undefined mechanisms 72.  NaCl increases ica 
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expression both by directly promoting transcription of the icaADBC operon and indirectly by 
repressing transcription of the icaR repressor 73.  Anaerobic 74 and nutrient-limiting 75 conditions, 
such as those found deep within a biofilm, induce PIA production.  This suggests that once the 
cells begin the process of biofilm formation, they enter a positive feedback loop, wherein more 
PIA leads to a denser, more hypoxic, less nutrient-dense biofilm, which in turn leads to more 
PIA production. 
When PIA was discovered to be produced by S. aureus, it was thought to be absolutely essential 
for biofilm formation 65.  This was such a prevalent belief that “slime” and “PIA” were used 
interchangeably with “biofilm matrix.”  This was later shown to not be the case as PIA-
independent biofilms were discovered 76.  This was particularly surprising because in S. aureus, 
unlike S. epidermidis, all sequenced isolates carry an intact icaADBC operon 77.  These PIA-
independent biofilms share some regulatory pathways with PIA-dependent biofilms, but also 
involve unique regulators.   
Several protein adhesins, including the previously mentioned Bap, have been shown to be 
sufficient to induce biofilm formation, even when the ica locus was mutated 22,78 .  Shortly after 
this observation was made, Smeltzer showed that deletion of the ica locus in UAMS-1, a relevant 
clinical isolate, did not inhibit biofilm formation 79.  In both cases, deletion of sarA abrogated 
biofilm formation, demonstrating a role for SarA in both PIA-dependent and PIA-independent 
biofilm regulation.  A likely role of SarA in PIA-independent biofilm regulation is its role in 
downregulating several extracellular proteases 80. 
The major quorum-sensing system in S. aureus is the Accessory Gene Regulator (agr) system.  
Quorum-sensing is often associated with biofilm formation, so agr is heavily studied in 
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relationship to biofilm regulation in S. aureus.  The results of these studies have been mixed, 
with different researchers showing that agr mutations inhibit, have no effect on, and promote 
biofilm formation 81,82.  This variability is typically explained as reflecting differences in strains 
and growth conditions 83. 
Another sensory system implicated in biofilm regulation is the ArlRS (Autolysis Related Locus) 
two component system 84.  When the system is disrupted by transposon insertion, an ica-deficient 
strain forms a robust biofilm.  Although little is written about this system’s role in biofilm 
regulation in S. aureus, two points are worth noting.  First, the biofilm phenotype of the arlRS 
mutant appears to be independent of autolysis.  Second, an arlRS mutant has less extracellular 
protease activity than the wild-type 85. 
Although there are diverse mechanisms of PIA-independent biofilm regulation, many of them 
have a common theme of either upregulating protein adhesins or downregulating extracellular 
proteases, which would effectively increase the abundance of extracellular protein adhesins.  
This underscores the importance of understanding the roles of the different molecules forming 
the biofilm matrix. 
Antibiofilm strategies 
The National Institutes of Health estimate that 80% of bacterial infections are biofilm-related 86.  
Because biofilms can be 1000-fold more resistant to antibiotics, these infections are typically not 
able to be cleared by antibiotic treatment.  To address this rising health problem, researchers are 
turning to alternative methods of biofilm inhibition. 
Natural products, small molecule metabolites produced by plants and many forms of marine life, 
are a rich source of anti-biofilm compounds.  Treatment with garlic extracts, for example, has 
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been shown both to clear pulmonary P. aeruginosa infections in a mouse model and to make in 
vitro biofilms more susceptible to antibiotic treatment 87.  Phloretin, an antioxidant found in 
apples, was able to inhibit biofilm formation in some E. coli strains (including 
enterohemorrhagic strain O157:H7) while leaving others (including commensal K12 strains) 
undisturbed 88.  Sea sponges are simple marine animals that produce a wide range of effective 
anti-biofilm compounds 89. 
One specific way that natural products inhibit biofilms is by inhibiting quorum sensing.  For 
example, flavonoids from various citrus species act as antagonists to the quorum sensing 
molecules homoserine lactone and AI-2 from V. harveyi 90.  Extract from grapefruit juice inhibits 
quorum sensing-mediated biofilm formation in E. coli 91.  Due to the success of natural products 
in this area, researchers have focused on finding other ways to inhibit quorum sensing, 
particularly ways to synthesize optimized inhibitors based on these natural compounds. 92,93.   
Antimicrobial peptides (AMPs) are small peptides produced by the host to fight off bacterial 
infection, and are highly effective against both planktonic and biofilm cells.  These peptides 
generally kill by permeabilizing the bacterial cell membrane, though other AMPs have different 
activities such as specifically destabilizing the biofilm matrix 94.  Lactoferrin and its semi-
synthetic derivatives are effective at reducing P. aeruginosa biofilms, presumably through their 
ability to chelate iron 95.  At sub-growth-inhibitory concentrations, Cathelicidins (the class of 
AMPs that includes human LL-37) inhibit biofilm formation of several species, including E. coli, 
S. epidermidis, and S. aureus 96. 
Much attention has been given to making various surfaces less hospitable for colonization and 
biofilm formation.  For example, Sharklet is a company that sells items ranging from iPhone 
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cases to urinary catheters stamped with a “micropattern” that they claim makes the item resistant 
to biofilm colonization 97.  Others coat the surface with silver nanoparticles, which are toxic to 
bacterial cells 98.  A recent trend has been to impregnate surfaces with the antibiotics like 
triclosan, but evidence has shown that triclosan and many other antibiotics actually increase 
biofilm formation 99.   
While there are many ways to inhibit biofilm formation, they all have limitations and drawbacks.  
Natural products are a treasure trove of bioactive compounds, but finding the ones that have a 
particular desired effect is searching for a needle in the proverbial haystack.  Quorum inhibitors 
often modulate other processes in both the host and the bacterium, making their effects hard to 
predict.  AMPs, while very powerful, have not evolved in a vacuum; as host organisms have 
evolved these peptides to fight infection, invaders have evolved proteases and other means of 
evading them.  The surface-centered solutions are limited by several factors, notably that in any 
medical context, the surface would be coated with host proteins, blocking any interaction 
between the biofilm and the surface.  Therefore new approaches to limit biofilm formation or 
disrupt established biofilms are urgently needed. 
Conclusion 
Biofilms are an important mode of bacterial growth, distinct from the planktonic state in which 
bacteria are often studied.  Many human health problems are caused by biofilm-associated 
infections and exacerbated by their resistance to antimicrobial chemotherapies.  Our 
understanding of how biofilm formation is regulated, and when and how biofilms form, is 
incomplete.  Although advances have been made to address the problems that stem from 
biofilms, there remains a significant need for practical and effective interventions.  
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The research laid out in this work begins with addressing the problem of a lack of reliable anti-
biofilm compounds for S. aureus. 
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Figure 1.  S. aureus biofilm. 
SEM image of S. aureus biofilm grown on catheter.  Reproduced from Boles and Horswill 100.  
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Figure 2.  The biofilm lifecycle. 
Biofilms form when planktonic cells attach to a surface, proliferate on that surface, and encase themselves in a 
protective matrix.  Under certain conditions, cells can disperse from the biofilm, reverting to a planktonic state.  
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CHAPTER 2 
IsaA inhibits biofilm formation 
Introduction 
Staphylococcus aureus is a gram-positive bacterium that exists both as a commensal, commonly 
colonizing humans, and as a deadly pathogen, possessing the ability to cause a multitude of 
infections 13,14,101.  The ability of S. aureus to colonize surfaces contributes to its lifestyle as both 
a commensal and a pathogen 102.  When colonizing a surface, S. aureus forms a structured 
community called a biofilm, in which cells are encased in a polymeric matrix.  Although the 
exact composition of this matrix varies greatly from strain to strain and between different growth 
conditions, its components include extracellular DNA, polysaccharides, proteins, and amyloid 
fibers 37,100.  The variability among biofilms formed by S. aureus contributes to its ability to 
colonize humans and cause many different kinds of biofilm-associated infections including 
osteomyelitis 103, endocarditis 7, and implanted device infections 104.   
Management of biofilm infections is extremely difficult due to their inherent resistance to both 
antimicrobial chemotherapies and the host immune response 102,105.  New approaches are needed 
to overcome the challenge of antimicrobial resistance.  Enzymatic disruption of the biofilm 
matrix and altering gene expression to induce biofilm disassembly are currently among the 
alternatives being investigated 100.  In addition, much research has focused on understanding the 
environmental conditions and bacterial molecular mechanisms that influence S. aureus biofilm 
development.  Exposure to glucose, osmolarity, ethanol, hemoglobin, temperature, and 
anaerobiosis, have been reported to affect biofilm formation and disassembly 41,100,106,107.   
Beyond these examples, little is known about the contribution of other environmental conditions 
and the molecular mechanisms that respond to them to control biofilm development. A deeper 
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understanding of these environmental cues may lead to innovative treatments for S. aureus 
biofilm infections.  Therefore, we set out to look for novel environmental factors that could 
influence S. aureus biofilm development by screening a small chemical library.   
The data presented in this chapter demonstrate that the polyphenolic compound tannic acid 
inhibits S. aureus biofilm formation by increasing the abundance of the lytic transglycosylase 
IsaA.  We show that, although tannic acid is a known antimicrobial, its antibiofilm effect is not 
due to growth inhibition.  Further, we show that increasing IsaA abundance by other means (such 
as through use of an overexpression vector) has the same effect.  Finally, we show that tannic 
acid’s antibiofilm effect can be seen in vivo, as black tea eliminates S. aureus throat colonization 
in a cotton rat model. 
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Materials and Methods 
Strains and plasmids 
The bacterial strains and plasmids used in this study are described in Table 1.  Strains of 
Escherichia coli were cultured in Luria-Bertani broth or on Luria agar plates.  For selection of 
chromosomal markers or maintenance of plasmids, E. coli antibiotic concentrations were (in 
µg/ml): ampicillin (Amp) 100; chloramphenicol (Cam) 10.  Except where noted, S. aureus 
strains were cultured in tryptic soy broth (TSB) or on tryptic soy agar (TSA).  For selection of 
chromosomal markers or maintenance of plasmids, S. aureus antibiotic concentrations were (in 
µg/ml): erythromycin (Erm) 10; chloramphenicol (Cam) 10.  All reagents were purchased from 
Fisher Scientific (Pittsburg, PA) or Sigma (St.  Louis, MO) unless otherwise indicated.  pKP1 
was created by PCR amplifying the isaA ORF from SH1000 using primers o82 (5’ – 
ATGCGGTACCCTTGCACTACGACATTCAAATTC – 3’) and o83 (5’ – 
ATGCGAATTCCTCTCCCCAATTTCTATGGG – 3’), and ligating this fragment into the 
multiple cloning site of pALC2073.  pKP1-IsaA.EQ was created by PCR amplifying the pKP1 
vector with overlapping primers o172 (5’ – TCATCGCTCGTCAATCA – 3’) and o173 (5’ – 
TGACCATTTGATTGACGAG – 3’), both of which contain the desired point mutation.  PCR 
product was treated with DpnI to remove the template plasmid and transformed.  Mutated 
plasmids were verified by DNA sequencing.   
Growth assays 
SH1000 cultures were incubated at 37°C in TSBg (66% TSB with 0.2% glucose).  OD600 was 
measured every 30 minutes, and ODs from log phase were used to calculate doubling time.  
Doubling times presented are averages from three biological replicates.  To calculate population 
density in stationary phase, cultures were incubated for 24 hours, washed in PBS, bath sonicated 
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for 4 minutes, serially diluted, and plated on TSA.  CFUs were counted the following day.  CFU 
counts presented are averages from four biological replicates. 
Biofilm assays 
Microtiter plate biofilms were grown as previously described 106.  Briefly, late-log phase S. 
aureus cultures were diluted 1:200 in a final volume of 200 µl 66% TSB in wells of a 96-well 
microtiter plate (Nunc 164688).  Glucose was added to a final concentration of 0.2% to induce 
biofilm formation.  Plates were incubated overnight at 37°C with shaking at 200 RPM.  After 
incubation, medium was removed by pipetting and wells were washed gently with 150 μl sterile 
water.  100 μl of 0.1% crystal violet was added and allowed to sit for 10 minutes.  Crystal violet 
was removed by pipetting and wells were again washed with 150 μl sterile water.  Plates were air 
dried and photographed.  To quantitate crystal violet staining, 150 μl of 40 mM HCl in EtOH 
was added to each well, pipetted to mix, and allowed to sit for 5 minutes.  Wells were again 
mixed, and 100 μl of stain was moved to a new plate and the absorbance at 595 nm was 
measured.  All microtiter plate quantitations with multigroup comparisons were analyzed by 
ANOVA and found to have p-values of <0.05.  Data sets were analyzed by a Dunnett’s test, and 
the p-values of these tests are listed in the applicable figure legends.   
Drip flow biofilms were set up and grown as described previously 37 with the growth medium 
being 2% tryptic soy broth (0.6 g/L) with 0.2% glucose (2 g/L).  After 5 days of growth, stainless 
steel coupons were removed with sterile tweezers and biofilm cells were harvested into 10 mL 
sterile phosphate buffered saline (PBS).  Samples were bath-sonicated for 10 minutes, serially 
diluted, and plated in plate count agar.  Colonies were counted the following morning. 
Flow cell biofilms were grown in 2% tryptic soy broth (0.6 g/L) with 0.2% glucose (2 g/L), 
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supplemented with tannic acid as indicated in the figure legends.  Confocal scanning laser 
microscopy and image analysis was performed as described previously (11).  Biofilms were 
treated with 330 nM Syto9 (LIVE/DEAD BacLight Bacterial Viability Kit; Invitrogen, Carlsbad, 
CA) 15 min prior to visualization. 
Cotton rat oropharyngeal colonization model 
To assess the ability of S. aureus to colonize the throat, a cotton rat throat colonization model 
was developed, based on previous studies done in mice studying Streptococcus pyogenes throat 
colonization 108.  Animal work was carried out in strict accordance with the recommendations in 
the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.  The 
protocol was approved by the Committee on Use and Care of Animals (UCUCA) of the 
University of Michigan (Permit Number:10394).  All efforts were made to minimize pain and 
discomfort during the procedure.  Female cotton rats (age 6-8 weeks) were obtained from Harlen 
laboratories and housed 3 per cage in a room kept at 23°C ± 2°C with 50-60% relative humidity 
and a 12-h light-dark cycle.  Rats were given tap water and rodent chow ad libitum and were 
acclimated to the laboratory environment for a minimum of 6 days before inoculation.  S. aureus 
(BB2146 or BB2497) was cultured overnight in TSB, harvested by centrifugation, washed and 
resuspended in phosphate buffered saline (PBS).  Female cotton rats were anesthetized, and a 
100-µl aliquot containing 1×105 CFU was instilled into the throat of anesthetized animals via 
gavage.  Throat cultures were taken using an alginate swab inserted into the oropharynx of 
anesthetized rats at indicated time points.  The swab was streaked onto Mannitol Salt Agar 
containing spectinomycin at 100 µg/ml and these plates were incubated for 24 hours at 37°C.  
The growth of S. aureus colonies on these plates was interpreted as the animal being colonized.  
Tea was given to indicated animals at 2, 5, and 8 days after the initial S. aureus colonization by 
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slowly delivering 200 µl of room temperature tea (prepared as described below) into the 
anesthetized animal’s throat via gavage.  Control animals were given the same volume of water.  
Animals were held upright during gavage and monitored closely to avoid pulmonary aspiration.   
Protein gels and Western blots 
Cultures were incubated overnight at 37°C with shaking in 66% TSB + 0.2% glucose.  Cultures 
were normalized by OD600 and cells removed by centrifugation.  Culture supernatants were 
concentrated by TCA precipitation, boiled for 10 minutes in SDS running buffer, run on a 14% 
polyacrylamide gel, and stained with Coomassie.  Western blotting was performed by boiling 
normalized culture supernatants for 10 minutes in SDS running buffer and separating on a 14% 
polyacrylamide gel.  Proteins were transferred to a PVDF membrane and probed with a 
polyclonal anti-IsaA antibody.  The IsaA antibody was generated in rabbits using the peptide 
DQLNAAPIKDGAYD, which corresponds to amino acids 48-61 of the IsaA protein. 
Tea 
Black tea was brewed by adding 100 ml boiling water to one bag of Twinings® English 
Breakfast tea and steeped for 7 minutes.  Tea was cooled to room temperature and filter 
sterilized.  Milk was made from powder to a concentration of 100 mg/ml (approximately the 
same concentration as is used to make milk from powder for consumption).  To precipitate 
tannins from tea, 5 μl milk was mixed with 25 μl tea and 20 μl water.  Mixture was allowed to sit 
at room temperature for 1 hour before use.  
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Results 
Screen for biofilm-modulatory compounds 
To identify chemicals and environmental conditions that influence S. aureus biofilm formation, 
we screened a collection of compounds contained in Biolog plates PM1-PM20 (Biolog, Inc., 
Hayward, CA) for the ability to inhibit or enhance surface colonization by SH1000, a common 
laboratory strain of S. aureus that descends from NCTC8325-4 109.  Briefly, the contents of each 
well of the Biolog plates were resuspended in 102 µl distilled water, and 50 µl of this 
resuspension was added to microtiter plate assays under both conditions that are typically 
biofilm-inducing (66% TSBg), and not biofilm-inducing (66% TSB).  Of the 1,920 conditions 
tested, 41 inhibited and 20 induced S. aureus biofilm formation (for a complete list, see Table 2).   
Tannic acid inhibits S. aureus biofilm formation in multiple biofilm models 
Among the compounds found to inhibit biofilm formation was tannic acid, a common component 
in teas and other plant-derived foods.  Because S. aureus colonizes the oropharynx and oral 
cavity 13,110,111 and is likely to encounter this compound during colonization, we focused our 
efforts on tannic acid.  We first confirmed and expanded the result from the screen, showing that 
tannic acid inhibited S. aureus biofilm formation in the microtiter plate biofilm assay.  This 
activity was seen at low micromolar concentrations in a concentration-dependent manner (Figure 
1A).   
To ensure that this effect was not unique to one particular in vitro assay, we also tested tannic 
acid’s ability to inhibit biofilm formation in flow cells and drip biofilm reactors.  Tannic acid 
inhibited surface colonization in both of these established biofilm model systems (Figure 1B, C).   
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Tannic acid is a mix of plant-derived polyphenolic compounds, the specific composition of 
which varies tremendously from manufacturer to manufacturer, as well as from lot to lot.  Two 
of the most abundant and consistently isolated components of commercially available tannic acid 
are gallic acid and pentagalloyl glucose 112 (Figure 2B).  Therefore, we also tested the ability of 
these compounds alone to inhibit S. aureus biofilm formation.  Gallic acid failed to inhibit S. 
aureus biofilm formation whereas pentagalloyl glucose inhibited at concentrations similar to 
those observed with tannic acid (Figure 2A).   
20 μM tannic acid does not inhibit growth of S aureus 
Because tannic acid is known to have antimicrobial activity, we investigated whether it affected 
S. aureus growth at the concentrations where we see anti-biofilm activity.  We incubated cultures 
in 66% TSBg supplemented with up to 20 μM tannic acid and observed growth (Figure 1D, 
Table 3).  In log phase, the doubling times of cultures grown with and without tannic acid were 
not statistically different.  We also allowed the cultures to grow to stationary phase and counted 
CFUs in each culture.  There was no statistical difference between final CFU counts. 
Tannic acid’s effect is not strain-specific 
To ensure that tannic acid’s biofilm-inhibitory activity was not specific to SH1000, we tested its 
effect on biofilms of 15 other S. aureus strains in microtiter plate assays (Figure 3).  These 
strains included both clinical isolates and established lab strains.  TSBg is a common medium for 
in vitro biofilm studies, but many of the strains we tested did not grow robust biofilms in this 
medium.  To better assay these strains, as well as to see if the phenotype was robust to different 
growth media, we also tested these 15 strains in a peptone-based medium (PNG).  Research in 
the Boles lab has shown that biofilms grown in PNG medium have altered matrix that contains 
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amyloid fibers 37.  The overwhelming majority of strains tested in both media formed less robust 
biofilms in the presence of tannic acid, suggesting that this effect is broadly applicable. 
Tannic acid inhibits biofilm formation only if added early in development 
To begin elucidating how tannic acid exerts its antibiofilm effect, we asked whether tannic acid 
could be added late in biofilm growth to disperse an already-grown biofilm, or if it needed to be 
added early.  We grew biofilms in the standard microtiter plate biofilm assay, adding tannic acid 
at different timepoints.  When tannic acid was added 1.5 hours after inoculation, the biofilm was 
inhibited.  When tannic acid was added 2.5 hours after inoculation, the biofilm was not inhibited 
(Figure 4).  
S. aureus supernatants display increased levels of IsaA in the presence of tannic acid 
We grew planktonic cultures of S. aureus in the presence of various concentrations of tannic 
acid.  We examined gross changes in the extracellular protein profile of culture supernatants by 
SDS-PAGE.  One band, migrating at approximately 26 kilodaltons, became more pronounced 
with increasing concentrations of tannic acid (Figure 5A).  This protein band was excised and 
identified by mass spectrometric analysis as the Immunodominant Staphylococcal Antigen A 
(IsaA).  IsaA is a putative lytic transglycosylase that has previously been implicated in cleaving 
peptidoglycan 113.  A polyclonal antibody was generated against IsaA and subsequent western 
blot analysis confirmed increased levels of IsaA present in culture supernatants supplemented 
with tannic acid (Figure 5B).   
Tannic acid does not regulate transcription of isaA 
We hypothesized that the increased extracellular abundance of IsaA was due to increased 
transcription of isaA in the presence of tannic acid.  We obtained reporter fusions of β-
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galactosidase to the isaA promoter and saw no increased β-galactosidase activity when the cells 
were grown with tannic acid (Figure 6A).  We were concerned that the tannic acid itself might be 
interfering with the β-galactosidase assay, so we also constructed a reporter fusion of YFP to the 
isaA promoter.  We saw no increase in YFP fluorescence when the cells were grown with tannic 
acid (Figure 6B).   
To ensure that our reporter fusions accurately reflected levels of transcription, we performed 
qRT-PCR to directly compare IsaA transcript levels in cells with and without tannic acid.  No 
significant difference was observed  between the two conditions (Figure 6C).  Taken together, 
these data strongly indicate that tannic acid does not cause increased transcription of isaA. 
An isaA mutant resists tannic acid mediated biofilm inhibition 
Since tannic acid affected IsaA abundance, we asked whether IsaA has a role in tannic acid 
biofilm inhibition.  An isogenic isaA mutant was assessed for its ability to form biofilms in the 
presence of tannic acid (Figure 7A and B).  In contrast to what we observed with the wildtype, 
increasing tannic acid concentration up to 20 µM had no effect on the ability of an isaA mutant 
to form a biofilm.  However, complementation of the isaA mutant by expressing isaA from its 
native promoter on a plasmid restored the susceptibility of this strain to the antibiofilm effects of 
tannic acid.  Taken together these results suggest that the antibiofilm effects of tannic acid are 
dependent upon the presence of IsaA.   
IsaA expression prevents S. aureus biofilm formation 
Since tannic acid increases the level of IsaA found in culture supernatants and results in reduced 
biofilm formation, we hypothesized that over-expression of IsaA would inhibit biofilm 
formation.  To test this hypothesis we cloned the isaA gene behind an inducible promoter and 
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assessed biofilm formation.   Induction of IsaA expression did not interfere with growth (data not 
shown) and resulted in no biofilm formation, whereas non-inducing conditions or the empty 
vector allowed biofilm formation (Figure 8A).   
The overexpression vector we used, pALC2073, is known to be leaky 114, and therefore IsaA 
levels in the absence of inducer were higher than in the empty vector controls (Figure 8B).  This 
increase in IsaA concentration in the non-inducing conditions did not affect biofilm formation.  
Taken together, these results suggest that it is possible to increase IsaA levels somewhat without 
having an effect, but that once IsaA levels hit a certain threshold, biofilm formation is inhibited. 
The putative transglycosylase active site is necessary for IsaA’s antibiofilm activity 
To investigate if the putative transglycosylase activity was required for the antibiofilm activity of 
IsaA, we constructed a point mutant in the conserved transglycosylase active site that would be 
expected to abolish activity.  Family 1 lytic transglycoslases, including IsaA, share a conserved 
ES motif, with the glutamyl residue being essential for catalysis 115,116.  In Salmonella enterica, 
the peptidoglycan-digesting activity of two lytic transglycosylases was dramatically reduced by 
replacing the conserved glutamyl residue with a glutamine 117.  We made the analogous mutation 
in IsaA’s conserved active site (E183Q) and expressed it from the plasmid pKP1.IsaA.EQ.  
Western blot analysis revealed that this construct produced a protein consistent with the size of 
the wildtype (Figure 8B).  However, overexpression of pKP1.IsaA.EQ did not result in biofilm 
inhibition (Figure 8A), suggesting that the IsaA putative transglycoylase activity is responsible 
for the protein’s antibiofilm effects.   
Spontaneous mutants that resist tannic acid biofilm inhibition fail to produce IsaA. 
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Although tannic acid inhibits biofilm formation in drip reactors grown for 3 days (see Figure 1), 
we noticed that extending the drip biofilm growth period to 5 days allowed a significant biofilm 
to form in the presence of tannic acid.  A single tannic acid resistant biofilm was broken up by 
sonication and plated onto nutrient agar to isolate single clonal colonies.  In testing 11 of these 
isolates, we found that three strongly resisted tannic acid biofilm inhibition (Figure 9A).  
Western blot analysis revealed that the three tannic acid resistant isolates also lacked IsaA in 
their culture supernatants (Figure 9B), further strengthening the link between IsaA and tannic 
acid mediated biofilm inhibition.   
The three resistant isolates were white in appearance, in contrast to the other 8 which had the 
golden coloring typically seen in S. aureus.  White coloring in S. aureus is due to a lack of the 
golden pigment staphyloxanthin, and is generally indicative of dysfunction in the Sigma B stress 
response system 118.  Sigma B mutants also characteristically have overabundant extracellular 
proteases 119.  As a preliminary test for protease activity, we cultured these isolates on milk-agar 
plates and observed a large zone of clearing around them (Data not shown).  These data 
suggested to us that the lack of IsaA in these isolates’ supernatants could be attributed to 
overabundant proteases due to a mutation in the Sigma B stress response system.  This 
hypothesis is further explored in Chapter 3. 
Tea inhibits S. aureus biofilm formation in an isaA-dependent manner.   
Tannic acid is a variable mixture of plant-derived polyphenols, consisting primarily of 
gallotannins 112, that has historically been used to precipitate proteins from solution 120.  Tannins 
are an abundant component of vascular plant tissue and help protect plants against bacterial and 
fungal infection 121.  In addition, tannins are thought to be partially responsible for the astringent 
taste of red wines and tea 122,123.  We therefore hypothesized that a tannin-containing drink, such 
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as tea, would directly affect biofilms by the same isaA-dependent mechanism as tannic acid.  We 
added freshly brewed black tea at various dilutions to a biofilm formation assay.  In the wildtype 
background, very low concentrations of tea (0.2% v/v or a 1:500 dilution) significantly inhibited 
biofilm formation (Figure 10A).  However, an isaA mutant formed a biofilm in the presence of 
tea at any concentration tested.  This phenotype could be complemented by expression of isaA 
from its native promoter on a plasmid (Figure 10C). 
Since tannins and proteins readily co-precipitate 124, we tested whether the addition of milk (a 
relevant source of protein) to tea would affect the antibiofilm properties of tea.  Milk was added 
to freshly brewed black tea at a concentration of 5 mg/ml, a concentration approximating an 
amount of milk a person might reasonably add to tea for consumption.  The mixture was 
vortexed briefly and allowed to sit at room temperature for 1 hour before adding directly to 
microtiter plate biofilm assays.  Unlike tea alone, the tea-milk mixture failed to inhibit biofilm 
formation (Figure 10B).  The lack of biofilm inhibition by the milk/tea mixture corresponded to 
the removal of polyphenols from the tea 125,126. 
Tea inhibits S. aureus throat colonization in an isaA-dependent manner.   
Emerging evidence suggests that, in addition to the nasopharynx, S. aureus commonly colonizes 
the oropharynx and oral cavity 13,110,111.  Since tea is a commonly consumed beverage that 
inhibits surface colonization in our in vitro models, we tested if tea could impact S. aureus throat 
colonization in vivo.  The cotton rat has previously been used to study S. aureus nasal 
colonization 127, and to use it as a model for S. aureus throat colonization, we first assessed if S. 
aureus would colonize the cotton rat oropharynx.  Oral inoculation with 1 x 105 S. aureus CFU 
resulted in reproducible oropharynx colonization, with 100% of animals being initially 
colonized, and reliable colonization remaining for over 2 weeks (Figure 11A). 
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To determine if tea ingestion influenced S. aureus oropharynx colonization, 200 µl of freshly 
brewed, room temperature black tea was administered via gavage to colonized rats at 2, 5, and 8 
days after initial colonization.  Tea ingestion reduced the number of animals colonized with 
wildtype S. aureus in the oropharynx, with 5 out of 6 animals not colonized after tea ingestion 
versus 1 out of 6 animals not colonized in a water gavage control group (Figure 11B).  An isaA 
mutant maintained higher levels of colonization upon tea ingestion, with 5 out of 6 animals 
remaining colonized post-treatment (Figure 11C).   
Given that the isaA mutant resisted tea treatment, we hypothesized that the one rat that remained 
colonized with wildtype S. aureus would be enriched for spontaneous mutants that have less 
IsaA in their culture supernatant.  We tested six colonies from that rat for IsaA production.  
Three of the six isolates had no detectable IsaA in their culture supernatants, and one had 
dramatically less IsaA than the wildtype (Figure 12A).  Similar to what was observed with 
spontaneous mutants from the drip reactors (Figure 9), we found that the four rat-throat isolates 
that had reduced or undetectable IsaA in their supernatants were resistant to tannic acid in the 
microtiter plate assay (Figure 12B).  The mechanism of these isolates’ resistance to tannic acid 
will be the focus of work discussed in Chapter 3. 
These results suggest that consumption of polyphenolic compounds, like those in tea, may 
reduce S. aureus oropharynx colonization in an isaA-dependent manner, and that mutations that 
lead to reduced IsaA abundance can arise spontaneously to confer resistance.   
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Discussion 
The ability of S. aureus to colonize surfaces and form biofilms contributes to its success as a 
commensal and pathogen.  S. aureus lives as a commensal attached to surfaces such as the skin, 
nasopharynx and oropharynx 13.  As a pathogen, S. aureus can attach to internal tissues such as 
bone, heart valves, or implanted medical devices 7,103,104.  Colonization by S. aureus increases the 
incidence of infection, and biofilm infections represent a serious clinical situation based on their 
recalcitrance to antibiotics, their persistence, and the propensity of organisms to detach and 
colonize new sites 100.  Relatively little is known regarding how natural products that are 
common in the human diet can influence S. aureus colonization and biofilm development.   
Therefore, understanding how S. aureus responds to natural products and different 
environmental conditions is an important issue that warrants further investigation. 
In this chapter we demonstrate that the polyphenolic compound tannic acid can inhibit S. aureus 
surface colonization in a multitude of biofilm models (Figure 1).  Analysis of liquid culture 
supernatants revealed increased levels of the protein IsaA when strains were cultured in the 
presence of tannic acid (Figure 5).  An isaA mutant was not susceptible to the biofilm inhibition 
effects of tannic acid and this phenotype was complemented by expressing isaA under control of 
its native promoter in trans (Figure 7).  Expression of IsaA from an inducible promoter inhibited 
biofilm formation and this was dependent upon a catalytic residue at the putative IsaA 
transglycosylase active site (Figure 8).  Black tea, a common source of tannic acid in the human 
diet, inhibited biofilm formation in vitro in an isaA-dependent manner (Figure 10).  We 
developed an animal model for S. aureus throat colonization and found that tea reduced throat 
colonization in an isaA-dependent manner (Figure 11).  After prolonged tannic acid or tea 
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treatment either in vitro or in vivo, isolates that were resistant to the antibiofilm effect of tannic 
acid appeared and these isolates failed to produce IsaA (Figures 9 and 12).   
Tannic acid has long been known to have antibacterial properties 128, bacteria are known to 
actively modulate gene expression in response to tannins 129,130, and recently it has been 
suggested that tannic acid has antibiofilm properties 131.  Pentagalloyl glucose (one of the major 
components of commercial tannic acid) and ellagic acid (another plant-derived polyphenolic 
compound) have also been shown to inhibit biofilm formation in S. aureus 132,133.  To the best of 
our knowledge, no genetic mechanism has been proposed for the antibiofilm properties of tannic 
acid or related polyphenols in S. aureus. Our work shows that tannic acid causes an increase in 
extracellular IsaA levels, and that increased levels of IsaA are able to inhibit biofilm formation in 
S. aureus.  At this time, the molecular mechanism leading to increased extracellular IsaA levels 
is not known, although we demonstrate here that it does not involve increasing transcription of 
isaA (Figure 6).   
One potential mechanism by which IsaA abundance could be increased is by tannic acid 
modulation of IsaA stability.  It is known that extracellular IsaA abundance trends with cell 
density, increasing exponentially during exponential growth and leveling off during stationary 
phase 134.  Our observation has been that in late stationary phase, IsaA abundance drops 
dramatically as the extracellular proteases become more abundant and more active.  It is possible 
that addition of tannic acid prevents the degradation of IsaA in stationary phase, which would 
appear as a dramatic increase when compared with untreated cultures where IsaA has been 
degraded.  At the time of the writing of this document, this hypothesis remains to be tested. 
Lytic transglycosylases have been extensively studied in E.  coli, where they have been shown to 
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cleave peptidoglycan at the β-1,4-glycosidic bond between N-acetylmuramic acid (MurNAc) and 
N-acetyl glucosamine (GlcNAc) 135.  By virtue of their ability to cleave the polysaccharide 
backbone of the peptidoglycan layer, lytic transglycosylases are thought to play a role in 
synthesis and degradation of the peptidoglycan.  It has been proposed that lytic transglycosylases 
play important roles in cellular elongation, septation, recycling of muropeptides, and pore 
formation 136. 
To the best of our knowledge, this is the first report describing a specific function of the lytic 
transglycosylase IsaA outside of cell wall maintenance in S. aureus.   The mechanism by which 
IsaA leads to biofilm inhibition remains unclear, but the evidence we present demonstrates that 
this activity depends on IsaA’s catalytic function as a lytic transglycosylase.  There are several 
ways in which cleavage of peptidoglycan could lead to a reduction in biofilm formation.  For 
example, peptidoglycan cleavage could change the composition of proteins and teichoic acids 
displayed on the cell wall, cleaving away factors necessary for surface colonization.  An alternate 
theory, discussed in Chapter 3, is that peptidoglycan cleavage could release a signaling molecule 
137, leading to modulation of biofilm-related gene expression.  
S. aureus nasal colonization is a significant risk factor for several infections including 
bacteremia, post-operative infections, and diabetic foot ulcer infections and contributes to the 
spread of this pathogen in hospital environments 17,138–140.  Many hospitals employ rigorous S. 
aureus infection control policies, including active surveillance of nasal colonization for patients 
and personnel, contact precautions, and isolation of colonized patients 141.  Current 
decolonization strategies involve applying topical agents such as mupirocin to the nose.  Several 
recent studies have identified the oropharynx as another common site of S. aureus colonization 
13,110,111.  Because hospital efforts to track and eliminate S. aureus colonization focus primarily 
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on the nasal cavity, these approaches are not likely to affect throat carriage and therefore this 
reservoir for future infection may persist. 
Our finding that tea inhibited S. aureus biofilm development in vitro and reduced throat 
colonization in an animal model may have important consequences.  In addition to helping us 
understand the function and role of IsaA, it gives us a safe, effective tool for decolonizing a 
second common site of S. aureus colonization, aiding in hospitals’ efforts to reduce the risk of 
infection and spread of this deadly pathogen.  Hot tea or coffee has previously been associated 
with reduced methicillin resistant S. aureus nasal colonization, suggesting that our results may 
translate to human colonization 142.  Understanding the effects of tannic acid and tea in 
decolonizing this reservoir, as well as the genetic mechanism underlying this effect, could lead 
us to more effective treatments for S. aureus colonization and infection. 
 
 
 
  
34 
 
 
Figure 3.  Tannic acid inhibits biofilm formation in S. aureus. 
(A) S. aureus does not form a biofilm in microtiter plate assay when cultured with micromolar concentrations of 
tannic acid (TA).  Biofilm formation was induced by supplementing the growth medium with 0.2% glucose.  Error 
bars represent standard deviation.  * indicates p<0.005 compared to + glucose, -TA control.  (B) S. aureus biofilm 
formation in a flow cell is dramatically reduced by treatment with 20 μM TA.  Shown are three dimensional image 
reconstructions of a z series created with Velocity software. Confocal laser scanning microscopy images are 
representative of three separate experiments and each side of a grid square represents 15 micrometers. (C) S. aureus 
forms significantly less biofilm in drip reactors when grown with 20 μM TA.  Arrow indicates biofilm growth.  Drip 
reactor biofilms were grown for three days and photographed before harvesting.  Cells were harvested from four 
replicate drip reactors and colony forming units were counted.  Error bars represent standard deviation.  * indicates 
p<0.01 compared to untreated control.  (D) S. aureus growth is not affected by TA at concentrations up to 20 
micromolar. 
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Figure 4.  Pentagalloyl glucose inhibits biofilm formation in S. aureus. 
(A) Two major components of commercial tannic acid are compared for anti-biofilm activity.  Pentagalloyl glucose 
(PGG) significantly inhibits biofilm formation.  Gallic acid (GA) causes no significant inhibition.  Error bars 
represent standard deviation.  * indicates p<0.01 compared to + glucose, -TA control.  (B) Chemical structures of 
gallic acid and pentagalloyl glucose. 
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Figure 5.  Tannic acid inhibits biofilm formation in multiple strains of 
S. aureus. 
Sixteen clinical isolates and lab strains of S. aureus grow weaker 
biofilms in the presence of tannic acid as compared to controls.  
Biofilms were grown in 66% tryptic soy broth (66% TSB) or peptone 
medium (PNG). 
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Figure 6.  Tannic acid inhibits biofilm formation only if added early. 
S. aureus biofilms grown in 66% TSB + 0.2% glucose with tannic acid added at indicated times after inoculation.  
TA added at 1.5 hours post-inoculation or earlier inhibits biofilm formation, while TA added 2.5 hours post-
inoculation or later does not. 
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Figure 7.  Tannic acid increases levels of IsaA in S. aureus culture supernatants. 
 (A) TCA-precipitated supernatants from overnight cultures of S. aureus grown in 66% TSB, supplemented with 
0.2% glucose and with the indicated concentrations of tannic acid.  When cultures are grown with higher 
concentrations of tannic acid, a band (indicated with an arrow) appears with an apparent molecular weight slightly 
below 26 kDa.  Band was excised and protein was identified by mass spectrometry as IsaA.  (B) Western blot of 
unprecipitated supernatants from overnight cultures probed with polyclonal anti-IsaA antibody.  IsaA levels in 
culture supernatants increase when culture is grown with tannic acid.   
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Figure 8.  Tannic 
acid does not 
increase isaA 
transcription. 
(A) SH1000 
isaA::lacZ (BB2186) 
grown 16 hours with 
and without tannic 
acid.  Beta 
galactosidase activity 
was measured by 
MUG assay and 
normalized to OD.  
No significant 
difference was 
observed.  (B) 
SH1000 + pIsaA-
YFP (BB2332) was 
cultured 25 hours in 
66% TSBg + 2 uM 
TA.  100 µl was 
removed to read YFP 
fluorescence and OD 
in a Tecan infinite 
reader.  Data 
presented is 
fluorescence/OD.  
(C) SH1000 grown 
for 16 hours in 66% 
TSBg with indicated 
concentration of 
tannic acid.  qRT-
PCR was performed 
to observe levels of 
IsaA mRNA 
compared to 16s 
rRNA.  Error bars 
represent standard 
deviation. 
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Figure 9.  isaA is necessary for tannic acid-induced biofilm inhibition.   
(A)  SH1000 (BB386), isaA::tetR (BB2183), isaA::tetR + empty vector (BB2184), and isaA::tetR 
+ isaA complement (BB2185) were assayed in microtiter plate for tannic acid-induced biofilm inhibition.  Strains 
lacking functional isaA were resistant to inhibition.  * indicates p<<0.001 compared to isogenic untreated control.  
(B) SH1000 (BB386), isaA::tetR + empty vector (BB2184), and isaA::tetR + isaA complement (BB2185) were 
assayed in a flow cell for tannic acid-induced biofilm inhibition.  isaA mutant was resistant to inhibition. 
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Figure 10.  Induced expression of IsaA inhibits biofilm formation. 
(A) SH1000 harboring empty vector (1209), isaA (2242), or E183Q-isaA (2333) under a tet-inducible promoter was 
cultured with 0.2% glucose and 250 ng/ml anhydrotetracycline (aTet).  No biofilm formed when IsaA was 
overexpressed.  A biofilm formed when E183Q IsaA was overexpressed.  Error bars represent standard deviation.  * 
indicates p<<0.001 compared to + glucose, - aTet isogenic control.  (B) Wild-type IsaA and E183Q IsaA are 
overexpressed when induced with 250 ng/ml aTet.  Western blot of SH1000 harboring empty vector (1209), isaA 
(2242), or E183Q-isaA (2333) under a tet-inducible promoter, with and without aTet induction, probed with 
polyclonal anti-IsaA antibody. 
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Figure 11.  Biofilm resistance to tannic acid in in vitro isolates is coincident with a reduction in IsaA expression. 
Strains derived from 11 S. aureus colonies isolated from a tannic acid-treated biofilm were tested for resistance to 
tannic acid-induced biofilm inhibition, as well as for IsaA production.  (A) 3 of 11 strains (2519, 2520, and 2524) 
are robustly resistant to tannic acid-induced biofilm inhibition in a microtiter plate biofilm assay.  (B) The same 3 
strains also do not have detectable IsaA in their culture supernatants.  Western blot of culture supernatants from the 
11 strains isolated from tannic acid-resistant biofilm (along with wild-type) probed with polyclonal anti-IsaA 
antibody. 
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Figure 12.  Black tea inhibits biofilm formation in S. aureus. 
(A) Black tea inhibits biofilm formation in a dose-dependent manner.  Biofilm formation was induced in a microtiter 
plate biofilm assay by supplementing the medium with 0.2% glucose.  Freshly brewed black tea was diluted into 
biofilm medium as indicated.  Error bars represent standard deviation.    * indicates p<<0.001 compared to + 
glucose, - tea control.  (B) When black tea is mixed with milk, the tea loses its biofilm-inhibitory effect.   Error bars 
represent standard deviation.    * indicates p<<0.001 compared to + glucose, - tea, - milk control.  (C) isaA is 
necessary for tea-induced biofilm inhibition.  SH1000 (BB386), isaA::tetR (BB2183), isaA::tetR + empty vector 
(BB2184), and isaA::tetR + isaA complement (BB2185) were assayed in microtiter plate for tea-induced biofilm 
inhibition.  Strains lacking functional isaA were resistant to inhibition.  Error bars represent standard deviation.    * 
indicates p<<0.001 compared to isogenic + glucose, - tea control.   
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Figure 13.  S. aureus throat colonization is reduced by tea in an isaA-dependent manner.   
(A) Cotton rats colonized with S. aureus via gavage to the oropharynx remain consistently throat colonized for 19 
days (N=6).  (B) Tea ingestion (square) via gavage at days 2, 5, and 8 reduces the number of animals colonized with 
wildtype S. aureus in the oropharynx to 1 out of 6 animals at days 7, 10, and 13 (N=6).   Control water ingestion 
(diamond) resulted in oropharynx  colonization of 6 out of 6 animals  at day 7 and 5 out of 6 animals at days 10 and 
13 (N=6).  Data were analyzed by Fisher Exact Test. *= p-value < 0.05.  (C) Colonization of cotton rats with an isaA 
mutant.  All animals remained colonized after water ingestion (diamond) via gavage at days 2, 5, and 8, and tea 
ingestion (square) via gavage resulted in 4 out of 6 animals colonized at days 7 and 10 and 5 out of 6 colonized at 
day 13.   
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Figure 14. Biofilm resistance to tannic acid in in vivo isolates is coincident with a reduction in IsaA expression. 
(A)  Western blot with anti-IsaA antibody on culture supernatants from 6 colonies isolated from the one rat that 
remained colonized after tea ingestion.  Three of the six colonies tested did not produce detectable levels of IsaA in 
culture supernatants.  (B) Six isolates were assayed in microtiter plate for biofilm resistance to tannic acid.  Isolates 
that reduced IsaA (2585-2588) were resistant while those with wild-type levels of IsaA were not. 
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Table 1. Strains and plasmids used in Chapter 2 
Strain Description Resistance Source 
BB1209 SH1000/pALC2073 Cm 143 
BB2146 SH1000 Spectinomycin resistant Spec 107 
BB2183 isaA::tet Tet 113 
BB2184 isaA::tet / pSK5630 Cm 113 
BB2185 isaA::tet / pMEL4 Cm 113 
BB2242 SH1000 / pKP1 Cm This work 
BB2333 SH1000 / pKP1.IsaA.EQ Cm This work 
BB2515 Dripper isolate None This work 
BB2518 Dripper isolate None This work 
BB2519 Dripper isolate None This work 
BB2520 Dripper isolate None This work 
BB2521 Dripper isolate None This work 
BB2522 Dripper isolate None This work 
BB2523 Dripper isolate None This work 
BB2524 Dripper isolate None This work 
BB2527 Dripper isolate None This work 
BB2528 Dripper isolate None This work 
BB2529 Dripper isolate None This work 
BB2585 Rat isolate Spec This work 
BB2586 Rat isolate Spec This work 
BB2587 Rat isolate Spec This work 
BB2588 Rat isolate Spec This work 
BB2589 Rat isolate Spec This work 
BB2590 Rat isolate Spec This work 
BB204 Newman 
 
144 
BB206 RN6390 
 
145 
BB207 RN6911 
 
146 
BB248 FRI1169 
 
147 
BB607 Blood isolate 
 
37 
BB608 Blood isolate 
 
37 
BB609 Blood isolate 
 
This work 
BB610 Bone isolate 
 
This work 
BB611 Bone isolate 
 
This work 
BB612 Bone isolate 
 
This work 
BB687 MW2 
 
148 
BB1263 LAC 
 
149 
BB707 Nasal isolate 
 
This work 
BB759 UAMS 
 
150 
    Plasmids 
   pSK5630 
 
Cm 113 
pMEL4 isaA under control of native promoter Cm 113 
pALC2073 
 
Cm 143 
pKP1 isaA under control of tet promoter Cm This work 
pKP1.IsaA.EQ isaA-E183Q under control of tet promoter Cm This work 
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Table 2. Compounds from screen of Biolog small molecule library that either promoted or inhibited biofilm 
formation. 
Biofilm inhibitory compounds: Biofilm promoting compounds: 
D-Serine Capric acid 
D-Sorbitol Itaconic acid 
Tween 20 Sodium chloride 
Tween 80 Ethylene glycol 
Mono Methyl Succinate Potassium chloride 
Inosine Sodium lactate 
D,L-Carnitine Sodium Benzoate 
Chondroitin Sulfate C 5-fluorouracil 
Putrescine Manganese II Chloride 
Guanosine EGTA 
Xanthine Cefmetazole 
D,L-α-Amino Caprylic Acid Cinoxacin 
Sodium Sulfate Sulfanilamide 
Ethylene Glycol Chloroxylenol 
Sodium Formate Sodium selenite 
Urea Sodium salicylate 
Sodium Lactate 5-fluoro 5 deoxyuridine 
Sodium Phosphate Pentachlorophenol 
Sodium Nitrate Tinidazole 
Sodium Nitrite Sodium caprylate 
Chloramphenicol 
 Neomycin 
 Rolitetracycline 
 Cupric Chloride 
 Boric Acid 
 Piperacillin 
 Promethazine 
 Cefmetazole 
 Nordihydroguaiaretic Acid 
 5,7-Dichloro-8-hydroxyquinoline 
 Rifamycin SV 
 Ferric Chloride 
 Tannic acid 
 Lidocaine 
 Sodium Bromate 
 Myricetin 
 2-Phenylphenol 
 Phenyl-methylsulfonyl-fluoride 
 Sodium caprylate 
 4-hydroxycoumarin 
 Pridinol 
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Table 3.  Growth rate and final culture density of S. aureus cultured in the presence of tannic acid. 
μM TA Doubling Time (min) CFU/ml after 24 hr (*10^9) 
0 35.6 ± 0.4 1.35 ± 0.77 
5 34.6 ± 2.6 1.4 ± 0.66 
20 36.2 ± 0.8 1.65 ± 1.03 
 
  
49 
 
Notes 
Much of the work in this chapter was published in the February, 2013 issue of Infection and 
Immunity151.  It is reproduced here with permission.  
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CHAPTER 3 
Analysis of resistant isolates 
Introduction 
Staphylococcus aureus is a major pathogen, responsible for 19,000 deaths per year in the United 
States 152.  S. aureus is also a commensal, asymptomatically colonizing roughly 30% of healthy 
adult humans 12.  In many cases of hospital infection, the colonizing strain appears to be 
responsible for the infection 18.  Because of this interplay between commensal and pathogenic 
lifestyles, hospitals make efforts to decolonize patients prior to invasive surgery.  Although this 
effort is valuable, S. aureus’s ability to adapt and evade treatments makes it vital that we expand 
our understanding of how S. aureus colonizes hosts and how it evades our efforts to fight it. 
The ability of S. aureus to form biofilms is central to both its pathogenic and commensal 
lifestyles.  A biofilm is a colony of bacterial cells that grows attached to a surface and is held 
together by a polymeric matrix.  Although the exact composition of this matrix varies greatly 
depending on species, strain, and growth conditions, it typically contains some combination of 
DNA, adhesive proteins, polysaccharide, and amyloid fibers 21,35,153,154.    
In chapter 2, we showed that tannic acid inhibited biofilm formation in S. aureus.  This effect 
was found to be due to an increased abundance of IsaA, a S. aureus lytic transglycosylase that 
cleaves peptidoglycan.  Rats colonized with S. aureus could be decolonized by treatment with 
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black tea, which is rich in tannic acid.  A small number of S. aureus colonies were isolated from 
one rat that resisted decolonization 151.   
In this chapter, we explore how that resistance to decolonization arose.  We sequenced the 
genomes of the isolates from the rat throat, as well as tannic acid resistant isolates from an in 
vitro biofilm.  We studied one of these isolates in depth, showing first that it formed a robust 
biofilm both in the presence of tannic acid and when IsaA was overexpressed.  This resistance 
was found to be due to a missense mutation in pknB, a eukaryotic-like serine threonine kinase 
that is conserved in all sequenced strains of S. aureus.  The mutation in pknB caused 
upregulation of the ica operon and thereby increased production of PIA.  The research presented 
in this chapter demonstrates how, even in the face of very effective treatments, bacteria are able 
to adapt and evade clearing.  
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Materials and Methods 
Strains and plasmids 
Strains and plasmids used in this chapter are shown in Table 4.  S. aureus strains were cultured in 
tryptic soy broth unless otherwise indicated.  Plasmids were maintained by growth in 10 µg ml-1 
chloramphenicol.   
Plasmids pJB38-ΔpknB and pJB38-pknB-P208R were both created by ligating different PCR 
products into pJB38 after digestion with EcoRI-HF and SalI HF.  The PCR fragment for pJB38-
ΔpknB was created by SOEing PCR using primers o437, o438, o452, and o440.  The PCR 
fragment for pJB38-pknB-P208R was created by SOEing PCR using primers o437, o493, o492, 
and o440. 
Strains BB2753 and BB2827 were created by allelic replacement using pJB38-ΔpknB and 
pJB38-PknB-P208R, respectively, as described 155.  All mutations were confirmed by Sanger 
sequencing. 
BB3016 was created by phage transduction.   The ica::tet mutation was moved from BB595 into 
BB2753 using ϕ11, as described 156. 
Biofilm assays 
Biofilm assays in the SH1000 background were performed as previously described 106.  Briefly, 
overnight cultures of S. aureus were diluted 1:200 in fresh 66% TSB (20g/l) + 0.2% glucose.  
200 µl final volume was added to wells of a 96 well microtiter plate (164688; Nunc).  Plates 
were incubated at 37°C shaking at 250 RPM for 16 hours.   
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For biofilms in the JE2 background, the assay was modified for stronger biofilm growth, as 
previously described 37.  Overnight cultures were diluted 1:200 in fresh PNG medium (20g 
peptone, 20g NaCl, 20g glucose per liter).  200 µl final volume was added to wells of a 96 well 
microtiter plate (164688; Nunc).  Plates were incubated at 37°C shaking at 250 RPM for 48 
hours. 
For the transwell assay, biofilms were grown as above with the following changes.  Growth 
medium was split between the upper and lower chambers for initial inoculation.  Medium 
containing BB2242 was added to the upper chamber, and the lower chamber was inoculated with 
different strains as indicated.  Anhydrotetracycline (aTet) was added to all wells at a 
concentration of 250 ng/ml. 
For the spent supernatant assay, biofilms were grown as above with the following changes.  
Overnight cultures were diluted in fresh 66% TSB (20g TSB per 1 l H2O) + 0.2% glucose and 
cultured in microtiter plate biofilm conditions for times indicated (2-6 hours).  At the time 
indicated, entire wells were mixed by vigorous pipetting to dislodge as much biofilm as possible.  
Cells were removed by centrifugation, supernatant was sterilized by passing through a 0.22 µm 
filter, and sterile supernatants were kept on ice until ready to use.  Overnight culture of BB1209 
was diluted 1:100 in 2x 66% TSB (40g/l) + 0.4% glucose.  100 µl sterile culture supernatant was 
added to bring final volume to 200 µl.  This was added to wells of a microtiter plate and grown 
as above. 
Following incubation, the biofilms were stained.  Medium was removed from the wells by 
pipetting, then wells were washed with 200 µl sterile water.  100 µl of 0.1% crystal violet was 
added and allowed to stain for 10 minutes.  Crystal violet was removed, then wells were washed 
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twice with 200 µl sterile water.  Plates were dried and photographed.  For quantification, stain 
was dissolved in 150 µl of destain solution (40 mM HCl in 95% ethanol).  After 10 minutes, the 
dissolved stain was diluted in destain solution to bring it into the linear detection range.  OD595 
was measured in a Tecan Infinite reader.   
Western blots 
Western blots were performed as previously described 151.  Cultures were normalized to OD600, 
then cells were removed by centrifugation.  Supernatants were boiled with SDS loading buffer 
and separated on 15% polyacrylamide gels.  Proteins were transferred to PVDF membranes and 
probed with a polyclonal rabbit-anti-IsaA antibody 151.   
High-throughput sequencing, alignment, and variant calling 
Genomic DNA was purified by phenol chloroform extraction.  DNA sequencing library 
preparation and sequencing on an Illumina HiSeq 2000 were performed by the University of 
Michigan DNA Sequencing Core. Fifty base single end reads were aligned to the S. aureus 
NCTC 8325 reference genome (Accession number NC_007795) using bwa aln and samse, 
version 0.7.8-r455, allowing reads to align only once to the reference sequence 157. Aligment 
files were generated using samtools and duplicate reads were marked using picard-tools 
MarkDuplicates version 1.118 with the following command line parameters: 
VALIDATION_STRINGENCY=LENIENT, REMOVE_DUPLICATES=true 158. Variants were 
called and VCF files generated using freebayes version 0.9.14-12-g88f4c76 with the command 
line parameters --standard-filters --ploidy 1 --min-alternate-fraction 0.8 --min-cov 10 159. 
Variants found in wild type control alignments were removed from the variants found in all other 
isolates using the vcf-isec command from vcf-tools version 0.1.12 with the command line 
parameters -f –c 160. 
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PIA dotblot 
Polysaccharide Intercellular Adhesin (PIA) was prepared and analyzed as described 161.  Briefly, 
biofilms were grown in a microtiter plate.  Multiple wells were homogenized by vigorous 
pipetting, then pooled.  Cells were pelleted at 6,000 x g for 5 minutes.  Pellet was resuspended in 
0.5 M EDTA and normalized by OD600.  Cells were boiled 5 minutes and spun at 6,000 x g for 
5 minutes.  40 µl of supernatant was mixed with 10 µl 20 mg/ml Proteinase K and incubated 60 
minutes at 37C.  Samples were boiled 5 minutes, then dotted onto a PVDF membrane and 
allowed to dry.  Membrane was probed with rabbit anti-PIA antibody graciously provided by 
Paul Fey 161, followed by Licor goat anti-rabbit secondary.  Blot was scanned on Licor Odyssey 
for visualization and quantitation. 
Germination assay 
B. subtilis spores were produced and purified as described 162.  Briefly, cells were grown 48 
hours in Difco Sporulation Medium (8g Difco nutrient broth, 1 ml 1M MgSO4, 10 ml 10% KCl, 
500 µl 1N NaOH in 1 L water.  After autoclaving and immediately before use, add 100 µl 1M 
CaNO3, 100 µl 10 mM MnCl2, and 100 µl 1 mM FeSO4).  Culture was centrifuged at 10,000 x g 
for 10 minutes, then washed three times with cold water.  Pellet was resuspended in cold water 
and shaken gently overnight at 4C.  Every day for 10-14 days, suspension was centrifuged 20 
minutes at 20,000 x g, resuspended in cold water, and returned to shake in the cold. 
Germination was measured by loss of optical density 162.  Briefly, spores were diluted in 10 mM 
Tris HCl (pH 8.4) and either germinants or peptidoglycan fragments were added.  OD580 was 
read every 10 minutes in a TECAN plate reader.  Graphs are presented as inverted (to show 
increase in germination rather than loss of OD) for the convenience of the reader.  
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Results 
Whole genome sequencing of tannic acid-resistant isolates 
In Chapter 2, we observed that when a drip reactor was treated with tannic acid for an extended 
period, a biofilm arose that resisted treatment (See Chapter 2, Figure 9).  We also observed that 
one rat of six remained colonized with S. aureus despite treatment (See Chapter 2, Figure 12).  
To gain better understanding of how tannic acid resistance arose, we analyzed isolates from these 
two tannic acid-resistant biofilms (See Table 5 for an overview of all isolates).   
As discussed in Chapter 2, we isolated 11 colonies from the in vitro system and 6 from in vivo.  
Although all were isolated from biofilms grown with inhibitory concentrations of tannic acid, 
only 3 of 11 and 4 of 6 were resistant to tannic acid’s antibiofilm effect when grown in pure 
culture.  We sequenced the genomes of the three resistant isolates from the drip reactor, as well 
as all six isolates taken from the rat throat.  The results of this sequencing are found in Table 6.  
Some notable results are discussed below. 
Lack of IsaA in rsbU mutants is due to a secreted factor 
Of the seven sequenced isolates that resisted biofilm inhibition by tannic acid, six had mutations 
in rsbU, while neither of the sensitive isolates did.  These six isolates all displayed phenotypes 
characteristic of inactive SigB, namely lack of the golden pigment staphyloxanthin and increased 
extracellular protease activity (See Chapter 2).  They also displayed reduced IsaA in their culture 
supernatants.  We hypothesized that the lack of IsaA in the culture supernatants of these isolates 
was due to breakdown by extracellular proteases.  
To simplify experimentation, we selected a representative non-resistant isolate (BB2515) and a 
representative resistant isolate (BB2519), both isolated from a drip reactor biofilm.  We had 
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previously performed our Western blots on these isolates using horseradish peroxidase-
conjugated antibodies, but by the time of the experiments in this chapter, we had access to the 
much more sensitive Licor Odyssey system.  Using this system, we observed extracellular IsaA 
abundance in wild type and the two isolates (Figure 13A).  As we saw previously, BB2515 has 
similar IsaA levels to wildtype, while BB2519 has dramatically less.  Interestingly, the more 
sensitive system clearly detects a set of bands at higher molecular weight corresponding to 
Surface Protein A (Spa) in the wildtype and BB2515.  In BB2519, these protein A bands appear 
farther down the blot, indicating degradation. 
We grew mixed cultures of wildtype with either BB2515 or BB2519 and probed their 
supernatants for IsaA.  When wildtype is cultured with BB2515, IsaA is present at levels similar 
to those observed in the wildtype, but when grown with BB2519, IsaA is severely diminished 
(Figure 13B), indicating that BB2519 is not simply deficient for IsaA production, but actively 
removes it from the supernatant. 
Further, we mixed cell-free supernatant from wildtype with cell-free supernatants from BB2515 
or BB2519.  When wildtype supernatant is mixed with supernatant from BB2515, IsaA is present 
at normal levels.  When mixed with supernatant from BB 2519, IsaA is diminished (Figure 13C).   
Because many of the S. aureus proteases are dependent on divalent cations, we cultured BB2515 
and BB2519 in TSB with and without EDTA to reduce extracellular protease activity, then 
Western blotted the culture supernatants for IsaA.  EDTA partially restored IsaA to the 
supernatant of BB2519, but did not affect levels in BB2515 (Figure 13D).  Taken together, these 
results suggest that the lack of IsaA in these six isolates is likely due to increased extracellular 
protease activity. 
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Rat throat isolate forms robust biofilm despite tannic acid treatment or IsaA 
overexpression 
Isolate BB2588 is the only isolate that both resists biofilm inhibition by tannic acid and does not 
have a mutation in rsbU.  In a microtiter plate biofilm model, it resisted tannic acid’s biofilm 
inhibitory effect, mimicking the phenotype of an isaA mutant (Figure 14A).  We showed in 
Chapter 2 that when wild-type S. aureus is grown with tannic acid, there is more IsaA found in 
the culture supernatant.  One explanation for this isolate’s resistance, and its phenotypic 
similarity to the isaA mutant, would be that it does not respond to tannic acid by increasing 
extracellular IsaA abundance.  To test this, we grew the isolate in 66% TSBg supplemented with 
tannic acid and western blotted the cell-free culture supernatants for IsaA (Figure 14B).  The 
trend seen in this Western blot is similar to what we had previously seen in the wild-type, with 
both strains demonstrating increased IsaA abundance in spent medium when grown with tannic 
acid. 
It is possible that, although IsaA abundance increases in this isolate, it does not increase to the 
same degree as in the wild-type.  To address this possibility, we transformed pKP1 into isolate 
BB2588 and induced IsaA production in our microtiter plate biofilm model.  When induced with 
anhydrotetracycline (aTet), IsaA levels are similar in the wild-type and the isolate (Figure 14C).  
Despite the increased levels of IsaA, the isolate forms a robust biofilm in the microtiter plate 
(Figure 14D). 
Variant in PknB leads to resistant biofilm 
We hypothesized that one or more of the variants found in the isolate was responsible for the 
biofilm phenotypes that we observed in Figure 14.  To narrow our list of candidates, we wanted 
to sort out which variants were likely to be deleterious to protein function from those that would 
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likely be benign.  Two web-based tools exist for such analysis, and we used both to reduce our 
chances of ignoring a relevant variant due to a false negative.  These two tools use different 
algorithms to perform essentially the same task; they both use a wide array of sequence 
information (including conservation across homologs and annotated active sites) to determine 
how likely a given amino acid substitution is to impede protein function.  First, we used SNAP2 
(Screening for Non-Acceptable Polymorphisms) 163, which scored two of the variants (those 
found in pknB and arlS) as being likely to affect protein function.  We also used SIFT (Sorting 
Intolerant From Tolerant) 164.  SIFT flagged those two variants, as well as two more (those found 
in ftsH and gluD).  These results allowed us to narrow our search to these four genes. 
To see if one of our four candidate genes was involved in biofilm resistance to tannic acid, we 
used transposon mutants from the Nebraska Transposon Mutant Library (NTML) 165.  
Transposon mutants for each of the four candidate genes, along with JE2 wildtype, were cultured 
in a microtiter plate biofilm assay.   The pknB::tn strain was the only strain that resisted tannic 
acid’s biofilm-inhibitory effect (Figure 15A).  This result suggested that PknB may play a role in 
the isolate’s resistance to tannic acid. 
To further demonstrate PknB’s role, we complemented the isolate by expressing PknB from a 
xylose-inducible promoter and challenged this strain with tannic acid in a microtiter plate 
biofilm.  Expression of PknB restores tannic acid sensitivity.  We also recreated the pknB variant 
in a clean SH1000 background, which was sufficient to give this new strain tannic acid 
resistance.  Resistance in this strain could also be complemented by expressing wild-type PknB 
(Figure 15B).  These results demonstrate that the pknB variant is responsible for the tannic acid 
resistant phenotype of the isolate. 
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PknB deletion is phenotypically equivalent to variant 
Because the biofilm phenotype of the isolate could be complemented by expressing wild-type 
PknB, we hypothesized that the pknB variant in the isolate rendered PknB non-functional and 
that this would be functionally equivalent to a clean pknB deletion.  We created a ΔpknB strain 
and observed its response to tannic acid in the microtiter plate biofilm assay.  The deletion strain 
was resistant to tannic acid, and sensitivity was restored when PknB was expressed from a 
plasmid (Figure 15B). 
To further demonstrate this, we also overexpressed IsaA in a ΔpknB strain.  When 
overexpressed, IsaA was found in the culture supernatant at similarly elevated levels in both the 
wild type and the ΔpknB strain (Figure 16B).  As in the isolate, the ΔpknB strain formed a robust 
biofilm even when IsaA was overexpressed (Figure 16A).  
Spent medium does not inhibit biofilm formation    
The exact role of PknB in S. aureus is unknown, though a model has been put forward by 
Dworkin’s group by analogy to PrkC, a homolog found in B. subtilis 137.  Briefly, it was 
demonstrated by Shah et al. that S. aureus PknB binds extracellular fragments of S. aureus 
peptidoglycan that diffuse away from dividing cells.  If PknB is heterologously expressed in B. 
subtilis spores, the spores will germinate in response to S. aureus peptidoglycan fragments.  
Maximal germination was achieved by adding concentrations as low as 1 ng/ml and as high as 
100 mg/ml of digested peptidoglycan.  Based on these data, they propose that PknB is activated 
by binding a fragment of peptidoglycan, and that this activation will have some effect on 
signaling within the cell. 
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Based on this model and on our own results that PknB was involved in biofilm inhibition, we 
hypothesized that PknB binds a fragment of peptidoglycan released by IsaA, and that as a result 
of that binding, biofilm formation is inhibited.  We set out to see whether such signaling 
occurred in S. aureus, and if so, to identify the signal. 
The simplest way to assay for this signal’s existence was to add spent medium from a culture 
overexpressing IsaA to a culture growing in a microtiter plate biofilm assay.  Contrary to our 
expectation, sterile spent medium from cells overexpressing IsaA had no effect on biofilm 
formation (Figure 17).  This suggested that no signaling molecule is released by IsaA or that 
such a signal is released but is unstable, making such a static addition of spent medium 
ineffective. 
Exogenous IsaA inhibits biofilm 
Given that spent medium failed to inhibit biofilm formation, we wanted to determine if IsaA’s 
effect could be communicated from one cell to another, or if the cells of a biofilm had to be 
producing IsaA themselves in order to be dispersed.  To test this, we used a transwell apparatus, 
which is essentially a microtiter plate divided into two chambers.  The chambers are separated by 
a 0.45 µm filter, allowing proteins, metabolites, and other small molecules to pass through, but 
preventing the passage of cells.  We grew cells overexpressing IsaA in the upper chamber and 
assayed biofilm formation of various strains in the lower chamber (Figure 18). 
Wildtype S. aureus overexpressing IsaA did not form a biofilm.  Wildtype S. aureus without 
IsaA overexpression has a distinct clearing in the middle of the well, corresponding to the part of 
the well directly below the filter.  A ΔpknB mutant formed a robust biofilm, even when IsaA was 
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overexpressed in the top chamber.  These results indicate that overabundance of IsaA inhibits 
biofilm formation, even when the IsaA is produced by cells outside the biofilm.   
SceD also inhibits biofilm formation 
Based on the hypothesis that PknB recognizes a specific fragment of peptidoglycan released by 
IsaA, we wondered if other peptidoglycan digesting enzymes could have similar effects on 
biofilm formation.  We overexpressed sceD, lytN, and ssaA in the microtiter plate biofilm assay.  
SceD is the other lytic transglycosylase in S. aureus, and is predicted to have the same substrate 
specificity as IsaA 113.  LytN and SsaA are amidases, which cleave between the glycan chain and 
the peptide stem.  Overexpression of sceD inhibited biofilm formation similar to isaA.  
Overexpression of either amidase had no effect (Figure 19).  The fact that the two lytic 
transglycosylases inhibit biofilm formation, as well as the fact that neither of the amidases we 
tested has this effect, suggests that SceD functions in the same way as IsaA to inhibit biofilm 
formation.  
Peptidoglycan fragments do not activate PknB 
We wanted to use Shah et al.’s B. subtilis heterologous expression system to develop a more 
sensitive assay to look for the signal that PknB recognized.  To do this, we first tried to replicate 
their results showing that B. subtilis spores heterologously expressing S. aureus pknB could be 
germinated by S. aureus peptidoglycan 137.  Spores of B. subtilis ΔprkC heterologously 
expressing pknB were successfully germinated by incubation with alanine alone or a mix of 
alanine and aspartic acid (Figure 20A).  Spores of the same strain were not germinated by 
addition of purified peptidoglycan that had been digested with mutanolysin (Figure 20B).  The 
concentrations of peptidoglycan shown are between 0.2 and 20 µg/ml, several orders of 
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magnitude higher than the minimum concentration shown by Shah et al. to induce maximal 
germination, and well within the effective range they tested. 
To rule out the possibility that the failure to germinate was due to PknB not being properly 
heterologously expressed, we attempted to germinate wildtype B. subtilis spores with B. subtilis 
peptidoglycan.  Spores were not germinated by incubation with purified peptidoglycan digested 
with mutanolysin (Figure 20C). 
PknB mutant’s resistance is a result of increased PIA 
In addition to searching for a diffusible signaling molecule, we were also interested in 
elucidating how PknB affects resistance to tannic acid and IsaA.  One way that the ΔpknB mutant 
could resist IsaA’s antibiofilm effect is by modulating its matrix composition.  We hypothesized 
that the pknB-dependent biofilm phenotypes we have observed could be due to overabundant 
Polysaccharide Intercellular Adhesin (PIA), which would lead to a sturdier matrix and a more 
robust biofilm 44.  This is consistent with our data showing that the ΔpknB mutant forms a thicker 
biofilm than the wildtype (Figure 4).  We created and tested a ΔpknB, ica::tet strain for tannic 
acid resistance.  The ica locus encodes the enzymes responsible for PIA synthesis, rendering this 
strain unable to produce PIA.  Where the ΔpknB strain is resistant to tannic acid, the double 
mutant is sensitive, similar to the wild-type (Figure 21A).  We also grew biofilms of the wildtype 
and ΔpknB strains, prepped PIA from those biofilms, and performed a dot blot with α-PIA 
antibody.  The ΔpknB strain’s biofilm had more PIA (Figure 21B).  Taken together, these results 
indicate that PIA production is increased in the ΔpknB strain, leading to a more robust biofilm 
that can withstand tannic acid stress. 
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Discussion 
In Chapter 2, we demonstrated that tannic acid effectively inhibited biofilm formation by S. 
aureus.  We also showed that, given time, resistance to tannic acid can occur both in vitro and in 
vivo.  Understanding how resistance arises can help us understand more about the mechanism by 
which tannic acid and IsaA inhibit biofilm formation.  In this chapter, we investigated how these 
biofilms developed resistance to treatment. 
We sequenced the genomes of nine isolates from tannic acid resistant biofilms, and found that 
six of them shared the common theme of rsbU mutations, leading to decreased extracellular IsaA 
(Figure 13) and robust biofilm formation (Chapter 2, Figure 9).  Another of the isolates had a 
mutation in pknB, which caused its resistance to tannic acid.  Complementing pknB restored 
sensitivity similar to the wild-type (Figure 15), and a ΔpknB mutant shared the resistant 
phenotype of the isolate (Figure 16).  The ΔpknB mutant had increased PIA, and knocking out 
PIA production in a ΔpknB mutant background restored sensitivity (Figure 21). 
RsbU (Regulator of Sigma factor B) has only one described function in S. aureus: to activate the 
alternative sigma factor SigB.  Because of this, rsbU mutations and sigB mutations lead to the 
same phenotypes and are typically considered to be functionally interchangeable 166,167.  The 
three sequenced isolates from a drip reactor biofilm demonstrated phenotypes consistent with 
rsbU or sigB mutation, namely lack of golden pigment and increased extracellular protease 
activity 119,168.  This protease activity leads to a decrease in extracellular IsaA abundance, which 
could explain how these cells are resistant to tannic acid’s antibiofilm effect.   
Interestingly, these rsbU mutants also appear to confer resistance on their neighbors, as they are 
the only ones of the 11 dripper isolates to have resistance when cultured individually.  
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Overproduction of extracellular proteases could be considered a communal good, and a way for a 
small subset of cells to adapt in a way that allows a larger community to thrive in the face of 
harsh conditions. 
The role of SigB and RsbU in S. aureus biofilm formation is controversial 119,169–172, with some 
labs finding that sigB mutants are unable to form a biofilm and others finding that they form very 
robust biofilms.  Our findings indicate that under our conditions, rsbU mutants do, in fact, form 
robust biofilms that resist inhibition.  Further research is needed to understand the underlying 
reasons for the phenotypic discrepancies reported in the literature. 
Three of the four rat-throat isolates that were resistant to tannic acid were also rsbU mutants.  
The other one owed its resistance to a mutation in pknB.  PknB is the only annotated 
serine/threonine kinase in S. aureus 173.  It spans the cell membrane, with an intracellular kinase 
domain and an extracellular PASTA (Penicillin binding And Serine Threonine kinase 
Associated) domain.   
The PASTA domain is known to bind peptidoglycan 174, but how that binding affects the cell has 
been debated.  The model that most S. aureus researchers have adopted comes from research by 
Shah et al. in B. subtilis 137.  In that organism, PrkC (the PknB homolog) is found on the surface 
of spores.  When neighboring cells divide, they emit specific fragments of peptidoglycan that are 
unique to growing cells.  PrkC binds these fragments, and in response to this binding, the spores 
germinate and enter an active growth phase.  They also show that the S. aureus PknB, when 
expressed in a ΔprkC mutant of B. subtilis, is able to cause germination in response to S. aureus 
peptidoglycan.   
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We found this model to be very promising, and we envisioned a role for PknB in a transition 
from a less active lifestyle (biofilm) to a more active one (planktonic).  We hoped to use the tools 
developed in the Dworkin lab to help us understand PknB’s contribution to biofilm regulation in 
S. aureus.  Specifically, we wanted to search for a signaling molecule that would be released by 
IsaA cleavage of peptidoglycan and would be detected by PknB.  Unfortunately, we were unable 
to replicate the results presented by Shah et al., as purified peptidoglycan did not germinate B. 
subtilis spores. 
Spent medium from cells overexpressing IsaA did not inhibit biofilm formation (Figure 17), but 
overexpression of IsaA did cause biofilm inhibition in neighboring cells (Figure 18).  When 
added to our inability to replicate Shah et al.’s data, this has caused us to reevaluate our 
hypothesis that a signaling molecule is released by IsaA and detected by PknB.  A competing 
hypothesis is that PknB threads through peptidoglycan to sense peptidoglycan rigidity.  This 
would be supported by our data, and will be discussed in Chapter 4. 
Polysaccharide Intercellular Adhesin (PIA) is a major component of the biofilm matrix 65.  PIA is 
produced and processed by genes found in the ica operon.  The regulation of this operon is 
complex and responds to many factors (See Chapter 1).  To the best of our knowledge, this is the 
first report directly linking PknB to PIA production.  Although the mechanism by which 
increased PIA confers tannic acid resistance to a biofilm is unknown, we would speculate that 
PIA is lending structural support to strengthen the biofilm matrix, counteracting the destabilizing 
effect of IsaA overexpression.   
How PknB affects PIA production is an open question that we are actively investigating.  PknB 
inactivates the catabolite control protein CcpA by phosphorylating two threonine residues on 
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CcpA’s DNA-binding surface 175.  CcpA, in turn, is known to regulate the ica operon 176.  It 
stands to reason that PknB could be regulating PIA through inactivation of CcpA. 
Our findings demonstrate two unique ways in which S. aureus biofilms can adapt to evade tannic 
acid treatment.  The first demonstrates how a subset of cells can adapt to provide resistance to 
their entire community.  The second method (increasing PIA production) could also have a 
community effect, but that remains to be tested.  Because S. aureus colonization is a major risk 
factor for surgical-site and other infections, hospitals make rigorous efforts to decolonize 
patients.  Understanding how the bacteria adapt to evade decolonization efforts is an important 
step to improving such treatments. 
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Figure 15. Tannic acid resistant dripper isolate degrades IsaA from supernatant. 
α-IsaA Western blots of culture supernatants from mid-log phase SH1000 (BB386) and two isolates from dripper 
biofilm grown with tannic acid.  IsaA and Surface Protein A (Spa) are marked.  (A)  Overnight cultures backdiluted 
and grown 4 hours.  IsaA does not accumulate in supernatant from isolate BB2519.  (B) Overnight cultures from two 
isolates mixed 1:1 with overnight culture of wildtype, then back diluted and grown 4 hours.  IsaA does not 
accumulate in supernatant from coculture of isolate BB2519 with wildtype.  (C) Cell-free supernatants from 1A 
mixed 1:1 (2515:386 and 2519:386).  A factor in 2519 supernatant eliminates IsaA from wildtype supernatant.  (D) 
Overnight cultures backdiluted in TSB containing 0.1 mM EDTA and grown 4 hours.  Growth in EDTA restores 
IsaA in BB519 supernatant. 
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Figure 16.  Rat throat isolate resists biofilm inhibition. 
(A) S. aureus isolate BB2588 forms robust biofilm in the presence of tannic acid in the microtiter plate biofilm 
assay.  Error bars represent standard deviation.  (B) α-IsaA Western blot of cell-free supernatants from cultures of 
BB2588 grown overnight in 66% TSBg + tannic acid.  Supernatant volume normalized to OD600 of culture.  IsaA 
level increases when grown with tannic acid.  (C) Microtiter plate biofilm assay of strains BB1209 (“WT + EV”), 
BB2242 (“WT + IsaA”), BB2768 (“2588 + EV”), and BB 2769 (“2588 + IsaA”) with aTet induction.  Isolate 
BB2588 forms a biofilm when IsaA is induced.  (D) α-IsaA Western blot of IsaA induction in BB2242 and BB2769.  
IsaA is induced to similar levels by aTet. 
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Figure 17. Variant in pknB causes resistance in isolate. 
(A) Four transposon mutants from NARSA library tested for tannic acid resistance in microtiter plate biofilm assay, 
compared to JE2 wildtype.  Biofilms grown in PNG medium.  Error bars represent standard deviation.  pknB::tn 
resists inhibition.  (B) Induced expression of pknB from a plasmid in three strain backgrounds tested for resistance to 
tannic acid in microtiter plate biofilm assay.  Error bars represent standard deviation.  pknB expression restored 
sensitivity in all three strains. 
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Figure 18.  ΔpknB mutant recapitulates isolate biofilm phenotype. 
(A) SH1000 and ΔpknB with IsaA overexpressed by aTet induction in microtiter plate biofilm assay.  Error bars 
represent standard deviation.  ΔpknB mutant’s biofilm formation is not inhibited by IsaA overexpression.  (B) α-
IsaA Western blot of IsaA induction in BB2242 and BB2767.  IsaA is induced to similar levels by aTet. 
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Figure 19.  Cell-free supernatant from IsaA-overexpressing cultures does not inhibit biofilm formation. 
Biofilm cultures of BB1209 and BB2242 were grown in TSBg + aTet.  At times indicated, supernatants were 
harvested.  Sterile supernatants were added 1:1 to fresh biofilm cultures of BB1209.  Following incubation, there is 
no difference between biofilms grown with supernatant where IsaA was overexpressed and where it was not. 
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Figure 20. Exogenously expressed IsaA inhibits biofilm formation. 
BB1209, BB2242, and BB 2766 were grown in the bottom chamber of a transwell apparatus with BB2242 in the 
upper chamber.  Cultures were grown in 66% TSBg + aTet to induce IsaA expression and biofilm formation was 
assayed in the bottom chamber.  BB1209’s biofilm formation was inhibited by a diffusible factor released by 
BB2242 in the upper chamber. 
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Figure 21. Overexpression of either S. aureus lytic transglycosylase inhibits biofilm formation. 
SH1000 harboring an empty vector (“EV”, BB1209), or overexpression vector for IsaA (BB2242), SceD (BB2664), 
LytN (BB2701) or SsaA (BB2702) was assayed for biofilm formation in the microtiter plate biofilm assay.  Biofilm 
formation was inhibited in strains overexpressing IsaA and SceD, but not LytN or SsaA. 
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Figure 22.  Peptidoglycan fragments do not cause germination of B. subtilis spores. 
(A) B. subtilis spores germinate in response to alanine or alanine plus aspartic acid.  Percent loss in optical density is 
proportional to fraction of spores germinated.  (B) B. subtilis ΔprkC + pknB(Sa) does not germinate when incubated 
with noted concentrations of mutanolysin-digested S. aureus peptidoglycan.  (C) Wildtype B. subtilis 168 does not 
germinate when incubated with noted concentrations of mutanolysin-digested B. subtilis peptidoglycan. 
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Figure 23.  ΔpknB mutant’s tannic acid resistance is due to overproduction of PIA. 
(A) Microtiter plate biofilm assay of SH1000 (BB386), ΔpknB (BB2753), and ΔpknB, ica::tet (BB3016) grown in 
66% TSBg + tannic acid.  Error bars represent standard deviation.  ΔpknB resists biofilm inhibition while ΔpknB, 
ica::tet is sensitive.  (B) PIA is more abundant in ΔpknB than in wildtype SH1000.  Bars represent quantitation of 
dot minus local background as measured by Licor Odyssey. 
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Table 4.  Strains and plasmids used in Chapter 3. 
Strain Description Resistance Source 
S aureus strains 
  BB386 SH1000 
 
177 
BB595 SH1000 ica::tet tet 106 
BB1209 SH1000/pALC2073 cm 143 
BB1415 SH1000/pEPSA5 cm 178 
BB2183 SH1000 isaA::tet tet 113 
BB2242 SH1000/pKP1 cm 151 
BB2268 JE2  erm 165 
BB2519 Drip reactor isolate spec 151 
BB2520 Drip reactor isolate spec 151 
BB2524 Drip reactor isolate spec 151 
BB2546 JE2 pknB::Tn erm 165 
BB2585 Rat throat isolate spec 151 
BB2586 Rat throat isolate spec 151 
BB2587 Rat throat isolate spec 151 
BB2588 Rat throat isolate spec 151 
BB2589 Rat throat isolate spec 151 
BB2590 Rat throat isolate spec 151 
BB2664 SH1000/pALC2073-sceD cm This Work 
BB2701 SH1000/pALC2073-lytN cm This Work 
BB2702 SH1000/pALC2073-ssaA cm This Work 
BB2753 SH1000 ΔpknB 
 
This Work 
BB2766 SH1000 ΔpknB/pALC2073 cm This Work 
BB2767 SH1000 ΔpknB/pKP1 cm This Work 
BB2768 BB2588/pALC2073 cm This Work 
BB2769 BB2588/pKP1 cm This Work 
BB2827 SH1000 pknB-P208R 
 
This Work 
BB2974 JE2 ftsH:tn erm 165 
BB2976 JE2 gluD::tn erm 165 
BB2978 JE2 arlS::tn erm 165 
BB3016 SH1000 ΔpknB, ica::tet tet This Work 
BB3030 SH1000 pknB-P208R/pEPSA5 cm This Work 
BB3032 SH1000 pknB-P208R/pEPSA5-pknB cm This Work 
BB3036 BB2588/pEPSA5 cm This Work 
BB3037 BB2588/pEPSA5-pknB cm This Work 
BB3039 SH1000 ΔpknB/pEPSA5 cm This Work 
BB3040 SH1000 ΔpknB/pEPSA5-pknB cm This Work 
    B. subtilis strains 
  BB2955 168 ΔprkC, amyE:pSpac-his6-pknB 
 
137 
BB2992 168 
 
179   
    Plasmids 
   pALC2073 
 
Cm 143 
pKP1 isaA under control of tet promoter Cm 151 
pEPSA5 
 
Cm 180 
pEPSA5-PknB PknB under control of xylose promoter Cm 181 
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Table 5.  Overview of isolates discussed in Chapter 3.  Indicated in rows is whether a given isolate has a variant in rsbU, a variant in pknB, whether a given 
isolate is resistant to tannic acid’s antibiofilm effect, and whether or not an isolate was subjected to whole genome sequencing. 
Source Dripper Rat Throat 
Isolate 2515 2518 2519 2520 2521 2522 2523 2524 2527 2528 2529 2585 2586 2587 2588 2589 2590 
RsbU variant? N N Y Y N N N Y N N N Y Y Y N N N 
PknB variant? N N N N N N N N N N N N N N Y N N 
TA resistant? N N Y Y N N N Y N N N Y Y Y Y N N 
WGS? N N Y Y N N N Y N N N Y Y Y Y Y Y 
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Table 6.  Results from whole genome sequencing analysis 
Genome 
position 
Reference 
sequence 
Variant 
sequence 
Ref 
AA 
Variant 
AA Locus tag 
Gene 
symbol Protein function 
BB2519 
1447592 C T V I SAOUHSC_01492 engA GTP-binding protein EngA 
2134154 C A   SAOUHSC_02301 rsbU sigmaB regulation protein RsbU 
2464717 G T A D SAOUHSC_02681 narG nitrate reductase subunit alpha 
2746906 G A A V SAOUHSC_02980  hypothetical protein 
2782815 ACCCCCCT ACCCCCT frameshift SAOUHSC_03008 hisF multifunctional imidazole glycerol phosphate synthase 
subunit/phosphoribosyl-AMP cyclohydrolase/phosphoribosyl-
ATP pyrophosphatase 
2805726 G A D N SAOUHSC_03033 nixA high affinity nickel transporter 
        
BB2520 
2134530 TAT TAAT frameshift SAOUHSC_02302 rsbU sigmaB regulation protein RsbU 
2746906 G A A V SAOUHSC_02980  hypothetical protein 
        
BB2524 
2134530 TAT TAAT frameshift SAOUHSC_02302 rsbU sigmaB regulation protein RsbU 
2746906 G A A V SAOUHSC_02980  hypothetical protein 
        
BB2585 
1442555 C A G V SAOUHSC_01485 ndk nucleoside diphosphate kinase 
1447592 C T V I SAOUHSC_01492 engA GTP-binding protein EngA 
1921335 C T S N SAOUHSC_02012 mgt glycosyltransferase 
2134154 C A   SAOUHSC_02301 rsbU sigmaB regulation protein RsbU 
2310015 C T G D SAOUHSC_02494 rpsE 30S ribosomal protein S5 
2464717 G T A D SAOUHSC_02681 narG nitrate reductase subunit alpha 
2746906 G A A V SAOUHSC_02980  hypothetical protein 
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Genome 
position 
Reference 
sequence 
Variant 
sequence 
Ref 
AA 
Variant 
AA Locus tag 
Gene 
symbol Protein function 
2805726 G A D N SAOUHSC_03033 nixA high affinity nickel transporter 
        
BB2586 
122322 A T N I SAOUHSC_00117 cap5D capsular polysaccharide biosynthesis protein 
418517 C G G R SAOUHSC_00415  hypothetical protein 
1705465 C A L I SAOUHSC_01803 aapA hypothetical protein 
1860179 G A S L SAOUHSC_01955 lukEv leukotoxin LukE 
2079361 G T D Y SAOUHSC_02244 dapE succinyl-diaminopimelate desuccinylase 
2091181 C A A E SAOUHSC_02258  hypothetical protein 
2134530 TAT TAAT frameshift SAOUHSC_02302 rsbU sigmaB regulation protein RsbU 
2182641 T G E D SAOUHSC_02361 rpmE2 50S ribosomal protein L31 type B 
2746906 G A A V SAOUHSC_02980  hypothetical protein 
2782815 ACCCCCCT ACCCCCT frameshift SAOUHSC_03008 hisF multifunctional imidazole glycerol phosphate synthase 
subunit/phosphoribosyl-AMP cyclohydrolase/phosphoribosyl-
ATP pyrophosphatase 
        
BB2587 
944248 G A E K SAOUHSC_00968  hypothetical protein 
2134530 TAT TAAT   SAOUHSC_02302 rsbU sigmaB regulation protein RsbU 
2310017 T A K N SAOUHSC_02494 rpsE 30S ribosomal protein S5 
2518792 G C A G SAOUHSC_02739  2-dehydropantoate 2-reductase 
2518799 T C K E SAOUHSC_02739  2-dehydropantoate 2-reductase 
2746906 G A A V SAOUHSC_02980  hypothetical protein 
2782815 ACCCCCCT ACCCCCT frameshift SAOUHSC_03008 hisF multifunctional imidazole glycerol phosphate synthase 
subunit/phosphoribosyl-AMP cyclohydrolase/phosphoribosyl-
ATP pyrophosphatase 
        
BB2588 
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Genome 
position 
Reference 
sequence 
Variant 
sequence 
Ref 
AA 
Variant 
AA Locus tag 
Gene 
symbol Protein function 
484434 C A A D SAOUHSC_00486 ftsH hypothetical protein 
852577 C G E Q SAOUHSC_00889 mnhA1 monovalent cation/H+ antiporter subunit A 
859989 C G R G SAOUHSC_00895 gluD glutamate dehydrogenase 
1138825 C G P R SAOUHSC_01187 pknB hypothetical protein 
1360474 C G G A SAOUHSC_01419 arlS hypothetical protein 
2170507 C G G A SAOUHSC_02345 atpA F0F1 ATP synthase subunit alpha 
2310012 C T G D SAOUHSC_02494 rpsE 30S ribosomal protein S5 
2569367 T A S C SAOUHSC_02797  hypothetical protein 
2746906 G A A V SAOUHSC_02980  hypothetical protein 
2782815 ACCCCCCT ACCCCCT frameshift SAOUHSC_03008 hisF multifunctional imidazole glycerol phosphate synthase 
subunit/phosphoribosyl-AMP cyclohydrolase/phosphoribosyl-
ATP pyrophosphatase 
        
BB2589 
484434 C A A D SAOUHSC_00486 ftsH hypothetical protein 
2310017 T A K N SAOUHSC_02494 rpsE 30S ribosomal protein S5 
2746906 G A A V SAOUHSC_02980  hypothetical protein 
2782815 ACCCCCCT ACCCCCT frameshift SAOUHSC_03008 hisF multifunctional imidazole glycerol phosphate synthase 
subunit/phosphoribosyl-AMP cyclohydrolase/phosphoribosyl-
ATP pyrophosphatase 
        
BB2590 
1695507 G T A D SAOUHSC_01797  DNA polymerase I 
2310015 C T G D SAOUHSC_02494 rpsE 30S ribosomal protein S5 
2514397 A T L I SAOUHSC_02733  hypothetical protein 
2746906 G A A V SAOUHSC_02980  hypothetical protein 
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Notes 
The whole genome sequence analysis in this chapter was performed by Jeremy Schroeder at the 
University of Michigan.  The Bacillus germination work was performed in collaboration with 
Tony Martini at the University of Iowa.  
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CHAPTER 4 
Future perspectives 
Introduction 
S. aureus is an important pathogen, causing thousands of deaths and many more hospitalizations 
every year 152.  Its ability to form a biofilm is central to both its pathogenic and commensal 
lifestyles.  Because of its genetic tractability, it is also an attractive model organism for studying 
community behaviors and dynamics.   
As we approach the post-antibiotic era, it is more important than ever for the scientific and 
medical communities to discover novel treatments for biofilm-associated infections.  Much 
research in recent years has focused on finding such treatments in natural products, such as 
tannic acid 87–89.  Unfortunately, this research is often exploratory, and it does not delve deep into 
mechanisms.  Many groups only go as far as the initial screen and confirmation, finding a 
compound that can inhibit biofilm formation without investigating the mechanism of inhibition. 
As has long been known, most antibacterial treatments select for their own failure.  After 
decades of widespread antibiotic use, for example, more and more bacteria are becoming 
antibiotic resistant.  Our own tannic acid treatment was no exception; we also saw resistance 
arise over a short period of time.  This highlights the importance of understanding not only the 
treatments we discover, but also the mechanisms by which they work.  As we understand the 
mechanisms, we can find both more effective ways to create the same effect (reducing the 
possibilities for 
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resistance) and we are better equipped to understand how bacteria will adapt to evade treatment.  
In this work, we describe a novel antibiofilm compound, as well as parts of the mechanism by 
which it operates.  In chapter 2 we describe a screen for antibiofilm compounds that lead us to 
find tannic acid.  We show that tannic acid increases extracellular abundance of the lytic 
transglycosylase IsaA, and that this increase is responsible for its biofilm-inhibitory effect.  We 
further show that this effect can be seen with dietary sources of tannic acid, such as tea, and that 
it is effective in vivo as well as in vitro.  Finally, we show that resistance can arise to tannic acid 
treatment both in vivo and in vitro. 
In chapter 3, we explore the mechanisms of resistance.  We show that most of the resistant 
isolates have mutations in rsbU, which likely gives them resistance by increasing production of 
extracellular proteases.  The only resistant isolate that did not have a mutation in rsbU had a 
mutation in pknB, which we show to be responsible for its resistance.  We show that this 
resistance is due to the pknB mutant producing more PIA than the wildtype, likely leading to a 
stronger biofilm matrix. 
Implications and Future Experiments 
Biolog screen 
Our first experiment in Chapter 2 was a screen of a small molecule library for compounds that 
could inhibit or promote S. aureus biofilm formation.  We found many more compounds that 
inhibited than promoted, which was not surprising given that disrupting a complex behavior is 
much simpler than accidentally turning it on.  Our initial ventures into tannic acid blossomed and 
turned into a very interesting, self-contained story.  However, there were many other hits in the 
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screen that were left unexplored.  A particularly interesting area for future work is the list of 
biofilm promoting compounds.   
Synergy with antibiotic treatment 
One exciting avenue of research is using biofilm inhibitory compounds in conjunction with 
antibiotics to increase efficacy of both.  This sort of treatment is very appealing because biofilms 
are much more resistant to antibiotics than planktonic cells (up to 1000x more resistant).   
A useful experiment for the future would be to pair antibiofilm compounds found in the Biolog 
screen (particularly tannic acid, about which we know the most) with various antibiotics, to see if 
they can act synergistically to more effectively clear biofilms.  This could be done in any of our 
in vitro models, the rat throat colonization model, or several other relevant in vivo models of 
biofilm infection or colonization. 
It is important to note that the bacterial adaptation to one treatment may affect susceptibility to 
the other.  For example, pknB mutants (which arose naturally in the rat throat model) are known 
to be more susceptible to a wide array of antibiotics 173,181,182. 
Is decolonization a good idea? 
In the rat throat model, we presented an extremely rapid, effective treatment for eliminating S. 
aureus colonization from the throat.  The mere fact that it is effective, however, does not answer 
the more important question of whether it is wise to use such treatments. 
Our data focus solely on S. aureus colonization in the throat, and we make no attempt to discern 
any effect on the other members of the normal flora occupying that microenvironment.  It is 
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possible that perturbing the delicate balance in this niche could lead to explosive growth of 
undesirable flora (as happens with C. difficile in the gut after antibiotic treatment). 
Another potential unintended consequence is selection for more virulent S. aureus.  We showed 
that resistance arose to tea treatment in the throat via mutation of two high-level genetic 
regulatory systems (pknB and rsbU).  pknB mutants have been shown to have increased 
expression of α-toxin, form larger abscesses, and cause a greater response by the host immune 
system 181,183.  In other strains and different models of infection, the opposite trend has been 
reported; pknB mutants of SH1000 and its parent 8325-4 cause significantly less severe 
bacteremia than their wildtype counterparts 184.  sigB mutants (and by extension, phenotypically 
equivalent rsbU mutants) are much less adept at survival within the host, and are quickly cleared 
by the host immune system 185. 
These factors together demonstrate the importance of understanding how resistance to tannic 
acid treatment arises.  If pknB mutations are a common adaptation, then we would need to weigh 
the benefits of decolonization against the potential costs of remaining colonized with a more 
virulent strain.  If rsbU mutations are common they would make any cells that resist treatment 
more sensitive to host immunity, making this treatment doubly effective. 
Off-pathway resistance 
We began our analysis of the resistant isolates hoping to find “on-pathway” mutations.  That is, 
mutations in genes that were directly involved in tannic acid’s inhibition of biofilm formation.  
The intent was to fill in some of the black boxes in our model and flesh out our knowledge of the 
pathway.  However, both of the genes we investigated appear to be “off-pathway,” having 
indirect effects to counteract the antibiofilm effects of tannic acid and IsaA.   
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This fact means that there are still avenues ripe for research within the model presented in this 
work.  How does tannic acid increase IsaA abundance?  How does IsaA inhibit biofilm 
formation?   
As for the question of how tannic acid increases IsaA abundance, we have hypothesized in 
Chapter 2 that it involves slowing or preventing IsaA’s degradation.  This would be feasible to 
test with a pulse/chase experiment looking at IsaA production and degradation throughout 
stationary phase, or by using chloramphenicol to halt protein synthesis, thereby following only 
degradation throughout stationary phase. 
There is not such a simple experimental avenue to find an answer to the second question.  How 
does IsaA inhibit biofilm formation?  We know that IsaA must be catalytically active, that it 
must accumulate, and that it can be counteracted by hyperproduction of PIA.  Beyond those facts 
we can only speculate.   
If overproduced PIA means a more stable, robust biofilm matrix 44, then it seems most 
reasonable to hypothesize that IsaA’s antibiofilm effect is a result of destabilizing the matrix.  
How this happens, however, remains unclear.  It is possible that it cleaves the peptidoglycan in 
such a way to release one or more of S. aureus’s many surface-associated adhesins.   
Another possibility is that peptidoglycan plays an unappreciated role in stabilizing the biofilm 
matrix.  Although peptidoglycan is not described as playing such a role, it is very possible that it 
could.  Because eDNA is commonly released into the matrix through cell lysis 30, there would be 
a large amount of cell debris present in the biofilm.  This would include eDNA, various 
intracellular proteins, and a massive amount of peptidoglycan.  It stands to reason that such a 
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resilient, sturdy polymer would be used in some fashion to give strength to the biofilm, and that 
degrading it would destabilize the matrix. 
An interesting experiment in this area would be to put PIA under our direct control (through the 
use of inducible promoters) rather than relying on a pknB mutation to upregulate its production.  
We could then grow biofilms with overexpressed IsaA and overexpressed PIA to see if 
overabundant PIA is sufficient to counteract IsaA’s inhibitory effect.  We speculate that it would 
be. 
Common mutation in all sequences 
In all 9 sequenced isolates, a variant appeared in SAOUHSC_02980, a hypothetical gene that has 
homology to an isochorismatiase-like protein (See Table 6).  The variant caused a single amino 
acid substitution.  This protein has no annotated function in any S. aureus strain we could find 
and has, to the best of our knowledge, never been studied in S. aureus. 
The isolates that were sequenced came from two independent experiments (an in vitro biofilm 
grown in a drip reactor and an in vivo biofilm grown in a rat throat). These experiments were 
performed months apart with independent cultures grown from the same -80ºC freezer stock. 
Because our sequences were aligned and variants called compared to our wild-type S. aureus (as 
opposed to simply aligning to a database), we know that this is not simply a variant that is 
present in the freezer stock of our wildtype.  If these results were from only one experiment, the 
simple explanation for the ubiquity of this variant would be that it was present in the colony 
chosen to begin the experiment.  However, it is astronomically unlikely that both of these 
independent experiments would begin with cultures that spontaneously contained the same 
variant.   
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It seems apparent that this variant is strongly selected for.  What is not apparent is whether it is 
selected for by growth in a biofilm generally or specifically by growth in a biofilm with tannic 
acid stress.  Unfortunately, given the data we have, we cannot make this distinction.  Our 
sequencing was a post hoc experiment, and we did not save any samples from drippers grown 
without tannic acid or from rats that were not treated with tea.   
To answer this question, we propose that the dripper experiment be repeated.  Biofilms would be 
grown in drip reactors for 5-7 days with and without tannic acid treatment.  When a resistant 
biofilm appears, cells would be harvested from both treated and untreated reactors.  Because we 
would only be interested in this particular variant (and not the entire genomes of the isolates), 
dozens of isolates could be sequenced cheaply and easily by Sanger sequencing.   
Contradictions with previous rsbU data 
Six of the seven resistant isolates had mutations in rsbU, and these isolates appeared to be 
resistant to IsaA simply by virtue of their overproduction of extracellular proteases.  This 
contradicts the dogma that protease production is associated with biofilm dispersal 169–172.  
However, Atwood et al. showed that this is dependent on growth conditions, with sigB mutant 
forming a much better biofilm than wildtype under some conditions, despite elevated protease 
levels.  This serves as a reminder that phenotypes can vary dramatically depending on strain 
variation and different growth conditions.  Some conditions and some strains appear to favor a 
biofilm matrix that is more dependent on one or another component.  In our strains, under the 
conditions we tested, rsbU mutants both produce more extracellular proteases and form very 
robust biofilms, suggesting that their biofilm does not depend as heavily on the protein adhesins 
as on other components. 
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Community goods – proteases 
A surprising result from Chapter 1 was that only a subset of cells isolated from tannic acid 
resistant biofilms was resistant to tannic acid when grown in pure culture.  This points to an 
interesting community dynamic, where some cells gain resistance by their own action and other 
cells gain resistance through the actions of their neighbors.   
The rsbU results presented in Chapter 2 suggest that extracellular proteases become a 
community good.  Proteases produced and exported by rsbU mutants degrade self-produced 
IsaA, as well as IsaA produced by wildtype neighbors.  Presumably, this would give resistance to 
their neighbors by creating an extracellular environment for all cells wherein IsaA does not 
accumulate to high, biofilm inhibitory levels. 
A simple extension of these results would be to coculture these rsbU mutants with wildtype cells 
in the microtiter plate biofilm assay to see if they do, in fact, confer tannic acid resistance to their 
neighbors.  Because the rsbU mutants are white while the wildtype cells are golden, it would be 
very simple to assay afterward how many cells of each type are present in the biofilm after tannic 
acid treatment. 
PIA in the S. aureus biofilm 
The pknB mutant produces more PIA than the wildtype, likely increasing overall biofilm 
integrity.  It is notable that, while S. aureus does produce some PIA, polysaccharide is a much 
less integral component of its matrix than its in, for example, the S. epidermidis matrix 77.  While 
PIA is higher in the pknB mutant, we observed in control blots that it is much lower in either 
strain than it is in S. epidermidis.   
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It is curious why this operon remains intact and functional in S. aureus if it is not necessary for 
biofilm formation and thought to be nearly always repressed.  It is possible that ica-activating 
mutations, such as the pknB mutation we observed here, are frequent enough in biofilms to make 
it advantageous to the bacteria to maintain a functional ica operon.  
Community goods – PIA 
We observed that the pknB mutant isolate was able to withstand both tannic acid and IsaA 
overproduction, and that this resistance was a result of PIA overproduction.  Because PIA is a 
major structural component of the biofilm matrix, it is possible that this stabilizing component 
could act as a community good, conferring resistance on PIA overproducers and non-
overproducers alike.   
It would be enlightening to perform biofilm assays where pknB mutants and wild type cells were 
mixed at different ratios, then harvested from the biofilm to see if the pknB mutant is able to 
confer resistance on neighboring cells.  Like the coculture experiment proposed for the rsbU 
mutant, this experiment would give us insight into how communities adapt to stress. 
Models of PknB function 
When discussing PknB’s function in S. aureus, there is near-unanimous acceptance of Shah et 
al.’s model 137.  Although hundreds of papers cite their work on PknB, very little has been 
published building on or further expanding their model.  To our knowledge, the only research 
that expands on this finding is a paper by Mir et al. which finds that Mycobacterium tuberculosis 
PknB binds to fragments of peptidoglycan, but that this binding has no effect on resuscitating 
cells from dormancy 186.  These results from M. tuberculosis are consistent with our observations 
that peptidoglycan fragments do not germinate B. subtilis spores. 
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According to this mycobacterial model, PknB binding to peptidoglycan fragments helps localize 
PknB to the midcell, but does not activate PknB.  In Mycobacterium, the specific activating 
signal has not been found, but it is thought to be related to peptidoglycan.  Adding certain 
peptidoglycan digesting enzymes (termed RPFs or Resuscitation Promoting Factors) has been 
shown to revive mycobacterial cells from dormancy.  It is possible that PknB threads through 
peptidoglycan, with its PASTA domains bound to intact peptidoglycan.  As peptidoglycan is 
degraded by RPFs or experiences other stress, it would become less rigid and more flexible, 
allowing PknB to also be more flexible.   
PknB regulates SigB activity 
It is worth noting that PknB positively regulates activity of the alternative sigma factor SigB 181.  
It seems likely, then, that SigB activity would be lowered in the pknB mutant, as well as isolate 
BB2588 which harbored a variant in pknB.  It is unlikely, however that the resistance of this 
isolate can be attributed to reduced SigB activity.  The isolate is golden in color, demonstrating 
that SigB is active enough to promote production of the pigment staphyloxanthin.  It also did not 
demonstrate increased protease activity as was seen in the isolates with rsbU mutations. 
Inactivation of the ica locus was sufficient to restore sensitivity to the isolate, indicating that 
PknB’s effects on SigB alone could not explain the isolate’s resistance.  The conditions under 
which PknB activates SigB are not defined.  In order to understand how the two might interact in 
a biofilm, more research into their interplay must be done. 
Conclusions 
In this dissertation, we demonstrate how tannic acid, a compound common in the human diet, 
can modulate biofilm formation by S. aureus, a pathogen and commensal commonly found in the 
human throat.  We begin to show a genetic mechanism by which this inhibition takes place, as 
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well as two distinct mechanisms that independently evolved for resisting inhibition.  We also 
propose some potential future directions for research that will further the findings presented here.  
Taken together, this provides us with important insights into how this relevant pathogen and 
model organism functions in a community to interact with its environment and adapt to tolerate 
new challenges. 
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